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ABSTRACT 
 
In this thesis I describe the development of an animal model of sustained hyperalgesia 
induced by exposure to ultraviolet (UV) A light to the rat’s tail, and the role of the C-
fibre barrage and peripheral afferent fibre sensitization in this model of hyperalgesia. 
Exposure of rats’ tails to UVA-light caused hyperalgesia to a noxious thermal 
challenge, immersion of the rats’ tails into 49°C water, and a noxious mechanical 
challenge, application of a static force of 3.9N by a bar algometer onto the rats’ tails. 
The hyperalgesia to the thermal challenge lasted eight days and hyperalgesia to the 
mechanical challenge continued for up to 16 days. Despite the sustained hyperalgesia, 
rats exposed to UVA-light showed no overt signs of morbidity as they gained weight 
normally and were mobile throughout the study. Histological examination of rat tail 
tissue showed mild, chronic inflammation in rats exposed to UVA-light and in rats that 
had their tails covered with a protective layer of aluminium foil during UVA-light 
exposure. This inflammation was therefore not responsible for the behavioural 
hyperalgesia. 
 
To investigate the role of C-fibre barrage in the development of hyperalgesia after 
UVA-light exposure, I pre-emptively blocked C-fibre activation during UVA-light 
exposure with the local anaesthetic bupivacaine. Injection of bupivacaine (1ml of 
0.5%), into the base of the tail prevented the development of thermal hyperalgesia to 
tail immersion in 49°C water. However, it did not prevent the development of 
hyperalgesia to a noxious punctate challenge. Thus the sustained mechanical 
hyperalgesia did not depend on the activation of the C-fibre barrage, but thermal 
 vi 
hyperalgesia did depend on the activation of a C-fibre barrage during the conditioning 
event of UVA-light exposure. 
 
Lastly, in rats anaesthetised with enflurane, I examined the responses of coccygeal 
primary afferent fibres to noxious thermal and mechanical stimulation after UVA-light 
exposure of their receptive fields on the tail.  I investigated only pure nociceptive 
afferents and ignored those afferents that responded to challenges in the noxious and 
non-noxious ranges. The peak firing rates and areas under the curve of post-challenge 
histograms, a measure of neuronal firing over time, of Aδ- and C-fibres were 
increased when noxious blunt and punctate challenges were applied to the rats’ tails 
after UVA-light exposure, showing that Aδ- and C-fibres that encode for noxious 
mechanical challenges were sensitized. The peak firing rate of C-fibres that were 
responsive to noxious thermal challenges were not increased after UVA-light 
exposure. Therefore, thermal hyperalgesia was probably mediated by sensitization of 
central nervous system neurones. 
 
In summary, I developed a model of sustained mechanical and thermal hyperalgesia 
caused by UVA-light exposure of the rat tail.  The thermal hyperalgesia was initiated 
by the C-fibre barrage, while mechanical hyperalgesia did not depend on the C-fibre 
barrage and peripheral afferent sensitization of Aδ- and C-fibres could account for the 
mechanical hyperalgesia.  
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PREFACE 
 
Chronic pain states are characterised by persistent pain, pain that persists longer than 
the temporal course of natural healing, enhanced pain sensation to noxious challenges 
(hyperalgesia) and the perception of non-noxious challenges as painful (allodynia). 
Although progress has been made over the last 25 years explaining the 
pathophysiological processes causing chronic pain, this increased knowledge has not 
translated adequately into clinical benefits. At best, chronic pain sufferers will 
experience sub-optimal pain relief through combination therapy of pharmacological 
agents and alternative treatments, such as acupuncture.  
 
Inadequate therapeutic success may result partly from the paucity of suitable animal 
experimental models of chronic pain and hyperalgesia. The majority of current animal 
models are not ideal. For example, the duration of hyperalgesia in most models tends 
to be too short for antihyperalgesic agents to be administered after the hyperalgesia 
has developed, which is commonly the situation in the clinical setting, or they leave 
the experimental animals in persistent pain, which leads to a constitutive deterioration 
in their health and, in addition to being unethical, may confound their response to 
nociceptive testing. In addition, the majority of chronic pain models employ either 
damage to nerves or injection of a noxious agent into tissue. As a result, the main 
focus of experimental models of chronic pain are models that mimic neuropathic pain, 
or models that mimic arthritic pain. 
 
I identified a model of hyperalgesia, previously described in the literature, caused by 
UVA-light. After exposure of the rat hind paw to UVA-light, rats developed 
 xx 
hyperalgesia to multiple noxious challenges for up to one week.  Therefore, UVA-light 
induced hyperalgesia would seem suitable for the testing of analgesic and anti-
hyperalgesic agents, as the agents could be given after the conditioning event, thereby 
more closely mimicking the clinical setting. Although the behavioural characteristics 
of the hyperalgesia have been well described in animals, several important issues 
remained unclear. For example, UVA-light caused chronic inflammation in human 
skin and it was assumed that the similar inflammation occurred in rats and was 
responsible for the hyperalgesia. Yet there are no reports of studies that have 
histologically examined rat, or any other animal, tissue after UVA-light exposure to 
confirm the presence of inflammation, nor correlated the possible inflammatory 
changes with behavioural hyperalgesia. In addition, there are no reports of studies that 
assessed the health of rats to ensure no constitutive deterioration. Moreover, data from 
studies where UVA-light was the conditioning event has been used interchangeably 
with data from studies using UVB-light as the conditioning event. There was therefore 
an underlying assumption that UVA- and UVB- light caused hyperalgesia through the 
same mechanisms. I felt such an assumption was not justified as the two wavelengths 
of light differed remarkably from each other in their physical properties and in the 
manner they caused erythema. I therefore developed my own new model of UVA-light 
induced hyperalgesia, and aimed to re-evaluate UVA-light as a conditioning challenge, 
primarily if there were any histological changes in rat tissue, any constitutive 
deterioration in rat physical condition, and to explore relevant physiological 
mechanisms of how UVA-light caused hyperalgesia.  
 
My thesis is presented as a series of experimental papers. Chapter 2 and 3 have been 
published in peer-reviewed journals and chapter 4 has been submitted for publication.  
 xxi 
 
The main focus of the my PhD thesis was validation of UVA-light as a suitable 
conditioning challenge for causing sustained hyperalgesia, and description of the 
underlying pathophysiological mechanisms that caused the hyperalgesia. Chapter 1 is 
therefore an overview of UV-light and the proposed mechanisms for how UV-light 
causes hyperalgesia. I have not included a description of the basic mechanisms of 
nociception and hyperalgesia, as there are texts, such as Textbook of Pain, that 
provide a far more detailed and thorough description of such topics than I could do. 
 
In the first experimental study of my thesis (Chapter 2) I aimed to establish an animal 
model of sustained hyperalgesia using both noxious thermal and mechanical 
challenges in rats by exposing their tails to UVA-light and to correlate those findings 
with inflammation in the tail. My second aim was to ensure that the rats experienced 
no chronic stress, as determined by weight loss and altered behaviour during 
experimentation. I found that rats exposed to UVA-light developed hyperalgesia to 
both noxious thermal and mechanical challenges, and that peripheral inflammation 
did not account for the sustained hyperalgesia. I therefore investigated the possible 
mechanisms that may account for the sustained hyperalgesia. These experiments are 
described in Chapter 3 and 4.  
 
In Chapter 3 I described the experiment I undertook to explore the role of the C-fibre 
barrage in causing UVA-light hyperalgesia. I administered a long-acting local 
anaesthetic into the base of the tail before UVA-light exposure to prevent C-fibre 
activation during UVA-light exposure. I found that thermal hyperalgesia, but not 
mechanical hyperalgesia was prevented by blocking the C-fibre barrage. This finding 
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was novel and showed that peripheral afferent sensitization did not account for the 
thermal hyperalgesia. 
 
In my final experiment (Chapter 4) I sought to explore the firing properties of 
peripheral afferent fibres in the rat-tail after UVA-light exposure. I examined the 
responses of coccygeal primary afferent fibres to noxious thermal and mechanical 
challenges after UVA-light exposure of their receptive fields on the tail. I confirmed 
that the fibres’ responses to noxious thermal challenges were unaltered by UVA-light 
exposure but that the responses to noxious mechanical challenges were enhanced, 
which corroborated my findings in Chapter 3.  
 
In Chapter 5 I have summarised the main findings and conclusions of my three studies 
and postulated on possible physiological mechanisms causing UVA-light hyperalgesia 
and possible studies for the future. 
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CHAPTER 1 
 
Introduction 
 
 2 
1. Ultraviolet light and mechanisms of ultraviolet-light induced pain and 
hyperalgesia 
 
1.1 Ultraviolet light 
 
Ultraviolet (UV) light is electromagnetic radiation that is composed of a range of 
wavelengths between 100 and 400 nm and is divided into UVA (320-400 nm), UVB 
(280-320 nm) and UVC (100-280 nm) light. UVA-light is further subdivided into UVAI 
(340-400 nm) and UVAII (320-340 nm). UV-light constitutes approximately five 
percent of the energy of extraterrestrial radiation, and has numerous clinical effects, 
both in the short and long term. Acute effects include sunburn inflammation, tanning, 
local and systemic immunosuppression, vitamin D synthesis and thickening of the 
stratum corneum, epidermis and dermis of the skin. Chronic effects include 
photoaging and skin cancer. In this thesis I shall discuss the processes by which UVA-
and UVB-light affect nociception and  I shall not discuss UVC-light, as it has not been 
used in models of acute nociception nor hyperalgesia.  
 
In my thesis I shall focus only on studies that describe how UVA- and UVB-light 
cause pain and hyperalgesia at the site of exposure and in the central nervous system.  
I shall discuss all studies published describing UVA- and UVB-light hyperalgesia and 
possible pathophysiological mechanisms. However, very little work has been done 
exploring spinal cord changes after UV-light exposure, and similarly very few 
electrophysiological studies have been conducted using UVA- and UVB-light as 
conditioning challenges. I have included this information in order to provide as 
comprehensive overview as possible of UV-light induced hyperalgesia.  
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1.1.1 Mechanisms of UV-light induced injury 
 
UV-light causes damage to skin through a cascade of reactions initiated by the 
absorption of UV-light energy by photoresponsive molecules in the skin called 
chromophores (Young, 1997). Each chromophore has a unique absorptive spectrum, a 
wavelength of light that has sufficient energy to initiate a chemical change in the 
chromophore. UV-light energy has the potential to initiate the biological response by 
either altering a target molecule, such as DNA, directly or to alter molecules 
indirectly through the generation of reactive oxygen species (Young, 1997). 
Chromophores in the epidermis and dermis that have absorptive spectra in the UV-
light range include nucleic acids, urocanic acid, proteins such as collagen and elastin, 
melanins and their precursors (Hawk & Parrish, 1983; Young, 1997).  Different 
wavelengths are absorbed by different chromophores, so the pattern of reaction 
occurring after exposure to UV-light radiation depends on the UV-light wavelength. 
For example, DNA absorbs UVB-light and does not absorb UVA-light. UVA-light acts 
primarily on melanins, NADH and NADPH, and UVB-light acts on nucleic acids, 
urocanic acid and proteins (Anderson & Parrish, 1981).  
 
UVA-light causes most of it injurious effects, in both humans and other animals, 
through generation of reactive oxygen species. UVA-light upregulates xanthine 
oxidase with the subsequent production of reactive oxygen species, such as 
superoxide and hydrogen peroxide (Hruza & Pentland, 1993; Halliday, 2005). When 
cells’ ability to neutralise oxygen radicals are exceeded cell damage occurs. Oxygen 
radicals cause significant damage to normal cellular processes by damaging DNA, 
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lipid peroxidation, and denaturation of proteins (Pathak et al., 1999; Halliday, 2005). 
Further damage also can be caused by increased production of reactive nitrogen 
species. UVA-light upregulates nitric oxide synthase with a subsequent increase in 
nitric oxide synthesis (Halliday, 2005). Nitric oxide combines with superoxide to 
produce a highly toxic reactive nitrogen species, peroxynitrite. Reactive nitrogen 
species damage DNA, alter enzyme activity, denature proteins, and initiate lipid 
peroxidation. Peroxynitrite-initiated DNA damage further interferes with cellular 
function by depleting ATP in cells. The enzyme poly (ADP-ribose) polymerase, 
activated after DNA damage by peroxynitrite, degrades NAD into its constituent 
components. Depletion of NAD causes a reduction in ATP formation with a 
subsequent decrease in cellular energy function that can lead to cell death (Halliday, 
2005).  
 
Unlike UVA-light, UVB-light causes most of its effects through direct damage of 
chromophores, such as DNA. However, UVB-light also induces the production of 
reactive oxygen and nitrogen species that ultimately leads to inflammation. UVB light 
causes DNA damage by directly altering DNA structure (Ichihashi et al., 2003; 
Matsumura & Ananthaswamy, 2004). Absorption of UVB-light by DNA causes the 
formation of mutagenic products called cyclobutane dimers, between adjacent 
thymine or cytosine residues, and pyrimidine dimers between adjacent pyrimidine 
residues. If these dimers are left unrepaired they can cause mutation in DNA 
sequences and subsequent carcinogenesis (Ichihashi et al., 2003; Matsumura & 
Ananthaswamy, 2004).  Alteration of DNA structure plays no role in UVB-light 
induced inflammation. 
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1.1.2 Characteristics of UVA- and UVB-light induced injury 
 
Exposure of skin, rodent and human, to UV-light causes erythema, increased tissue 
temperature, oedema, pain and pruritus, followed by tanning and epidermal 
thickening (Hruza & Pentland, 1993). Erythema as a marker of UV-light induced 
injury can be measured, usually with Laser Doppler, as a change in skin blood flow. 
The time course of erythema development, temporal pattern of erythema development 
(monophasic or biphasic), duration of erythema, and histological changes are 
dependent on the wavelength and dose of UV-light (Hruza & Pentland, 1993). The 
differences in erythema duration, time course of erythema and histological changes 
after UVA- and UVB-light irradiation are as a result of the differing penetration depths 
of the different wavelengths. UVA-light penetrates to the deeper dermis, while UVB-
light penetrates through the epidermis into the upper dermis (Gilchrest et al., 1981; 
Gilchrest et al., 1983). 
 
In humans, UVA- and UVB-light exposure causes a dose-dependant erythema i.e. the 
higher the dose the greater and longer the changes in skin blood flow (Bickel et al., 
1998; Hoffmann & Schmelz, 1999; Koppert et al., 1999; Benrath et al., 2001; Sycha 
et al., 2003; Gustorff et al., 2004a; Gustorff et al., 2004b; Harrison et al., 2004; 
Koppert et al., 2004; Sycha et al., 2005; Sycha et al., 2006). However, the dose of 
UVA-and UVB-light required to cause similar effects differ significantly with UVA-
light requiring a dose a 1000 times greater that that of UVB-light to cause similar 
effects (Hruza & Pentland, 1993). Low-dose UVA-light irradiation of buttock skin 
caused an immediate erythema that peaked at 8 hours and lasted for 48 hours 
(Gilchrest et al., 1983). However, at a higher dose the erythema peaked 48 hours after 
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UVA-light exposure, and persisted for over 72 hours (Harrison et al., 2004). 
Therefore, UVA-light caused a monopahsic erythema. In contrast, UVB-light caused a 
biphasic erythema. UVB-light irradiation of the forearm caused a dose-dependent 
increase of skin blood flow for more than 96 hours post-irradiation, with two peaks of 
blood flow, the first at 12 hours and the second at 36 hours after irradiation (Benrath 
et al., 2001).  
 
As with the erythema, histological changes occurred within human skin almost 
immediately after UVA- and UVB-light exposure. There were significant differences 
between the histological changes associated with UVA-and UVB-light, with UVA-light 
causing predominantly dermal changes and UVB-light causing both epidermal and 
dermal changes (McCregor & Hawk, 1999). Because of its low absorbance in the 
epidermis UVA-light caused very little epidermal injury, with the injury that did occur 
being characterised by spongiosis and the absence of inflammatory cells (Soter, 
1990). Within the deep dermis blood vessels were severely damaged by UVA-light 
with endothelial swelling, extravasation of red blood cells, platelet aggregation, 
endothelial cell separation, extravascular fibrin deposition and partial occlusion of the 
vessels due to perivascular oedema (Kumakiri et al., 1977). A mixed perivascular 
cellular infiltrate, consisting of predominantly monocytes and T lymphocytes with 
few neutrophils, encroached on the deeper dermal vessels (Kumakiri et al., 1977; 
Gilchrest et al., 1983). The histological features after UVA-light exposure were 
consistent with a chronic inflammatory process.  
 
The histological changes caused by UVB-light exposure extend from the epidermis 
through to the dermis, and the higher the dose the 
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changes. The first observable histological changes coincided with the first peak of 
erythema. Arterioles, capillaries and venules are dilated and there was a complete 
absence of inflammatory cells (Gilchrest et al., 1981). The perivascular cellular 
infiltrate that eventually developed after UVB-light exposure, coinciding with the 
second peak of erythema, consisted of neutrophils, T lymphocytes and mononuclear 
cells. Within the dermis, endothelial swelling and perivascular cellular infiltrate was 
present 24 hours to 72 hours after UVB-light exposure (Gilchrest et al., 1981). The 
histological features after UVB-light exposure were consistent with an acute 
inflammatory response.  
 
A proviso for the above histological findings was the suitability of controls used. 
Usually biopsies were taken from two sites. The first site was from skin that was 
irradiated with either UVA- or UVB-light, while tissue taken for comparison was 
removed from a site that was not irradiated. I believe they did not adequately control 
for all variables. Tissue exposed to UV-light increases in temperature, as a result of 
the UV-light and the heat generated from UV-light lamps. Therefore it was possible 
that an increase in tissue temperature and not the UV-light could have caused 
histological changes. A more suitable control would have been to expose all tissues 
taken for biopsy to UV-light, and have blocked the UV-light, but not the heat, over 
the control tissue.   
 
In summary, in humans UVA-light causes a monophasic erythema characterised by a 
chronic inflammatory process within the deeper dermis of the skin. UVB-light causes 
a biphasic erythema characterised by an acute inflammatory process within the 
epidermis and superficial dermis of the skin. Typically the changes after UVA-light 
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exposure are of a shorter duration and less severe than those after UVB-light exposure. 
The differences in erythema duration, time course of erythema and histological 
changes after UVA- and UVB-light irradiation are as a result of the differing 
penetration depths of the different wavelengths, as UVA-light penetrates to the deeper 
dermis while UVB-light penetrates through the epidermis into the upper dermis. 
 
1.1.3 Pro-inflammatory metabolites produced by UV-light irradiation 
 
Numerous substances are produced within the skin and systemically after UVA- and 
UVB-light irradiation, such as prostaglandins, histamine, kinins, nitric oxide, 
interleukins, colony stimulating factors, growth factors, interferons, chemokines and 
neuropeptides (Kondo, 1999; Clydesdale et al., 2001; Zegarska et al., 2006). They 
each have a role in co-ordinating the multiple effects observed in the skin after UV-
light irradiation. However, I am going to focus only on those substances that are 
involved in nociception and hyperalgesia.  
 
After UVA-light exposure, prostaglandin (PG) E2, PGD2, and PGF2α are increased at 
the site of irradiation (Gilchrest et al., 1981; Hawk et al., 1983). Prostaglandins are 
synthesised by a constitutive cyclooxygenase (COX) enzyme, COX-1, and an 
inducible enzyme, COX-2. Their increase parallels the time course of erythema, such 
that they are produced immediately after UVA-light exposure, their peak 
concentrations coincide with the peak period of erythema, and they return to pre-
exposure levels one to three days after UVA-light exposure of human skin (Gilchrest 
et al., 1981; Hawk et al., 1983). Nevertheless, the role of prostaglandins in UVA-light 
induced erythema is unclear as topical or intradermal application of indomethacin, a 
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potent inhibitor of COX –1 and -2, has no effect on erythema caused by UVA-light 
(Morrison et al., 1977). Similarly to prostaglandins, histamine was increased after 
UVA-light exposure of skin (Gilchrest et al., 1981; Hawk et al., 1983). Human mast 
cells degranulate and released histamine four hours after UVA-light exposure. 
Histamine production peaked 9 to 15 hours after exposure and returned to baseline 
levels within 24 hours (Gilchrest et al., 1981; Hawk et al., 1983). However, 
antihistamines did not abolish UVA-light induced erythema. Therefore, the exact role 
of histamine in UVA-light induced erythema is unclear, and it has been proposed that 
histamine sensitizes irradiated tissue to multiple pro-inflammatory agonists such as 
prostaglandins and bradykinin, and facilitated the production of prostaglandins in the 
keratinocytes (Pentland & Jacobs, 1991). Contradictory findings have been reported 
regarding keratinocyte pro-inflammatory cytokine production after UVA-light 
irradiation with some studies reporting an increase in pro-inflammatory cytokine 
production while others reporting no changes (Kondo, 1999). The reasons for these 
differences are unknown but it may be due to different doses of UVA-light being used, 
or more likely different light sources and experimental protocols. After UVB-light 
exposure, inflammation within skin consists of three overlapping phases. The first 
phase, early vasodilatory phase is mediated by PGE2 and nitric oxide. The second 
phase is characterised by infiltration of inflammatory cells, namely neutrophils, T 
lymphocytes and mononuclear cells, and the release of multiple pro-inflammatory 
mediators. The last phase is the regressive phase, in which anti-inflammatory 
substances, such as interleukin (IL) –10, are released within the skin and the erythema 
and inflammation resolves (Terui & Tagami, 2000). My discussion will focus on the 
first two phases, because the pro-inflammatory mediators released in these phases are 
also those mediators that have pro-nociceptive and hyperalgesic effects.  
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After UVB-light exposure, as with UVA-light exposure, PGE2, PGD2, and PGF2α are 
increased in the skin (Black et al., 1978a; Black et al., 1980). Their time course 
increase parallels the time course of erythema in exactly the same way as after UVA-
light exposure i.e. they are produced immediately after UVA-light exposure, their peak 
concentrations coincide with the peak period of erythema, and they return to pre-
exposure levels one to three days after UVB-light exposure of human skin (Black et 
al., 1978a; Black et al., 1980). But unlike erythema caused by UVA-light, UVB-light 
induced erythema can be suppressed partially through the inhibition of eicosanoid 
synthesis by means of the administration of indomethacin either topically (Snyder & 
Eaglstein, 1974a; Rhodes et al., 2001), intradermal injection (Snyder & Eaglstein, 
1974b), or oral ingestion (Black et al., 1978b). Similarly COX-2 inhibitors suppress 
UVB-light induced erythema (Wilgus et al., 2000; Wilgus et al., 2002). A single dose 
of indomethacin, which inhibits mainly COX-1 isoenzymes, had no effect on 
erythema when administered 24 hours after UVB-light exposure (Farr & Diffey, 
1986), but repeated administration of indomethacin starting 24 hours after UVB-light 
exposure did inhibit erythema induced by UVB-light (Rhodes et al., 2001). The partial 
suppression of erythema by COX inhibitors suggests that eicosanoids, although vital, 
are not the sole mediators of UVB-light induced erythema, through prostaglandin 
production by constitutively expressed COX 1 and inducible COX 2 is essential in the 
onset and maintenance of UVB-light induced erythema.   
 
Another potential mediator of UVB-light induced early vasodilatation is nitric oxide 
(Terui & Tagami, 2000; Rhodes et al., 2001). Nitric oxide synthesis within the human 
skin was increased after UVB-light irradiation (Rhodes et al., 2001), and the early 
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vasodilatory phase was temporarily, but not permanently, blocked by the injection of 
a nitric oxide synthase inhibitor into the skin (Rhodes et al., 2001). Therefore, it is 
possible that nitric oxide is continuously produced through the sustained activation of 
nitric oxide synthase. However, differing effects of nitric oxide on vasodilatation are 
seen at different UVB-light doses. At lower doses of UVB-light exposure, erythema 
can be abolished by the administration of a nitric oxide synthase inhibitor alone. 
However, at higher UVB doses, erythema cannot be abolished with a nitric oxide 
synthase inhibitor alone, but it can be abolished in combination with indomethacin 
(Rhodes et al., 2001). Taken together, it appears that prostaglandins and nitric oxide 
mediate the early vasodilatation of the first phase of the inflammatory response 
caused by UVB -light. 
 
In the second phase of the UVB-light induced inflammatory process, pro-
inflammatory cytokines IL-1 (Kupper et al., 1987), IL-6 (Oxholm, 1992), IL-8 
(Kondo et al., 1993; Strickland et al., 1997) and tumour necrosis factor (TNF)-α 
(Oxholm et al., 1988; Kock et al., 1990; Oxholm, 1992; Strickland et al., 1997) are 
increased within the human epidermis after UVB-light exposure and are expressed by 
keratinocytes (Kondo, 1999; Clydesdale et al., 2001). Langerhans cell production of 
cytokines has not been as well investigated as keratinocyte production and the role of 
Langerhans cells in inflammation caused by UVB-light is unclear (Clydesdale et al., 
2001). UVB-light exposure also caused an increase in circulating pro-inflammatory 
cytokines in humans (Urbanski et al., 1990) and mice (Saade et al., 2000). TNF-α and 
IL-1 suppress keratinocyte and melanocyte proliferation, regulate collagen and 
collagenase synthesis, activate and stimulate the migration of lymphocytes in the 
affected area, induce the production of other cytokines and PGE2, and promote the 
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upregulation of the cellular glycoproteins intracellular adhesion molecule–1 (ICAM-
1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial adhesion molecules 
(E selectin) (Clydesdale et al., 2001). The cellular glycoproteins orchestrate the 
recruitment and activation of neutrophils, monocytes and T lymphocytes from the 
blood to cutaneous tissues (Kondo, 1999). IL-1 also stimulates the release of 
histamine from mast cells (Kondo, 1999). IL-6 induces proliferation and chemotaxis 
of keratinocytes, sustains the viability and function of Langerhans cells, activates T 
lymphocytes, inhibits melanocyte proliferation and prolongs the survival of mast cells 
(Kondo, 1999). IL-8 is chemotactic for both neutrophils and T lymphocytes and 
induces proliferation and chemotaxis of keratinocytes (Kondo, 1999; Terui & Tagami, 
2000).  
 
As with pro-inflammatory cytokines vasoactive neurokinins contribute to peripheral 
inflammation after UVB-light irradiation. Substance P and calcitonin gene-related 
peptide (CGRP) are vasoactive neurokinins that are found in the branches of primary 
afferent neurones that end near blood vessels and can be released from the peripheral 
terminals of these nerves (Zegarska et al., 2006). Substance P and CGRP content in 
skin nerve fibres, in the rat hind paw, are increased after UVB-light exposure of the rat 
hind paw (Benrath et al., 1995; Eschenfelder et al., 1995). When released 
peripherally, as occurs in a variety of inflammatory models, substance P enhances 
vascular permeability and blood flow, and CGRP causes long-lasting vasodilatation 
(Zegarska et al., 2006). Substance P also stimulates macrophages to produce PGE2, 
superoxide ions, and thromboxane B2, regulates the expression of adhesion 
molecules, stimulates keratinocytes to produce pro-inflammatory cytokines and is 
chemotactic for leukocytes (Zegarska et al., 2006). When neurokinin, substance P 
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receptor, antagonists are administered either systemically, via subcutaneous injection, 
or topically, UVB–light induced erythema and oedema were reduced in rats (Benrath 
et al., 1995; Eschenfelder et al., 1995). CGRP receptor antagonists injected 
intradermally predictably had no effect on UVB-light induced oedema, but did reduce 
UVB-light induced erythema (Benrath et al., 1995). Although, substance P and CGRP 
contribute to peripheral inflammation after UVB-light irradiation, their role in UVB-
light induced hyperalgesia is less clear. The end-points measured in the above studies 
by Benrath and colleagues were markers of inflammation and not hyperalgesia. 
Therefore, the role of substance P and CGRP in hyperalgesia still is unclear. 
 
Neurokinin content within the central nervous system also was altered after UV-light 
exposure of the rat hind paw (Gillardon et al., 1991; Gillardon et al., 1992a; Polgar et 
al., 1998). Substance P content within the spinal cord at L4 and L5 segments, 
bilaterally, was decreased after UVA-light exposure of the rat hind paw (Polgar et al., 
1998). In contrast to the lumbar segments, substance P content was increased on the 
contralateral side of the midthoracic segments (Polgar et al., 1998) UVB-light 
irradiation of the rat hind paw caused an increase of intracellular CGRP content in the 
spinal cord (Gillardon et al., 1992a) with a decrease in CGRP messenger RNA in the 
L4 and L5 dorsal root ganglia (Gillardon et al., 1991). Since no further experiments 
have been published exploring altered central nervous system neurokinin content, the 
significance of the above findings is unknown.  
 
In summary, UVA- and UVB-light cause an increase in prostaglandins and histamine 
in skin. Their increase parallels the time course of erythema, such that they are 
produced immediately after UV-light exposure, their peak concentrations coincide 
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with the peak period of erythema, and they return to pre-exposure levels as the 
erythema resolves. However, the administration of suitable antagonists does not 
reverse nor attenuate UVA-light induced erythema. Therefore the role, if any, of pro-
inflammatory mediators in UVA-light induced erythema is not known. In contrast, 
UVB-light induced erythema is reversed by the administration of suitable antagonists. 
Furthermore, UVB-light, but not UVA-light, causes an increase in pro-inflammatory 
cytokines and neurokinins. Therefore, UVB-light induces a typical inflammatory 
milieu within irradiated tissue and UVA-light does not. 
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1.2 Ultraviolet-light induced hyperalgesia 
 
Perkins and Campbell first described UV-light as a conditioning event for the 
development of hyperalgesia in 1992, and subsequently used pharmacological 
interventions, immunohistochemistry and electrophysiology to explore the 
physiological mechanisms underlying the UV-light induced hyperalgesia. In the 
following sections of this chapter I describe key studies, in detail, to highlight major 
contributions to the field. 
 
1.2.1 Time-course of UV-light induced hyperalgesia: behavioural studies  
 
UVA-light and UVB-light cause hyperalgesia in a variety of animals (Table 1). 
Exposure of the rat hind paw to UVA light causes thermal hyperalgesia of the 
irradiated paw that can last for 10 to 13 days (Perkins et al., 1992; Perkins et al., 
1993; Perkins & Kelly, 1993; Davies et al., 2005). There was up to a 70% reduction 
in response latencies to a noxious thermal challenge of the irradiated paw on the first 
day after exposure to UVA-light, with peak hyperalgesia being reached three days 
after exposure to UVA-light. The hyperalgesia was constant for five to seven days, 
with full resolution of hyperalgesia 12 to 13 days after UVA-light exposure.  
Hyperalgesia also developed in the hind paw that was not exposed to UVA-light, but 
was present for only seven days and was not as severe as in the paw exposed to UVA-
light (Perkins et al., 1992). The presence of hyperalgesia in non-exposed areas implies 
that either central sensitization had occurred or peripheral nocieptors were 
upregulated.  
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Table 1: UV-light induced hyperalgesia 
 
Species Light wavelength Site irradiated Noxious challenge Duration of hyperalgesia Reference 
      
Rats UVA Hindpaw Radiant heat 7 days (Perkins et al., 1992) 
   Randall-Sellitoe test   
      
 UVA Hindpaw Radiant heat 10 days (Perkins et al., 1993) 
      
 UVA Hindpaw Radiant heat ≥ 4 days (Perkins & Kelly, 1993) 
      
 UVA Hindpaw Radiant heat ≥ 6 days (Thompson et al., 1994) 
   Randall-Sellitoe test 4 days  
      
 UVA Hindpaw Von Frey hairs ≥ 4 days (Boxall et al., 1998) 
   Randall-Sellito test   
      
 UVA Hindpaw Pin prick No hyperalgesia (Davies et al., 2005) 
   Radiant heat 2 days  
   Acetone drop test 5 days  
   Von Frey hairs 5 days  
      
 UVB Hindpaw Von Frey hair 10 days (Bishop et al., 2007) 
   Water bath 7 days  
      
Mice UVB 
Dorsal surface of 
body Tail flick test 4 days (Saade et al., 2000) 
   Hot plate test 3 days  
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Species Light wavelength Site irradiated Noxious challenge Duration of hyperalgesia Reference 
      
Pig UVB Not stated Von Frey hairs ≥ 2 days (Rukwied et al., 2008) 
   Heat pad ≥ 2days  
      
Humans UVA Thigh Radiant heat Not present 
   Impact Not present 
(Hoffmann & Schmelz, 
1999) 
      
 UVA Buttock Radiant heat ≥ 3 days (Harrison et al., 2004) 
   Impact ≥ 3 days  
      
 UVB Thigh Radiant heat 4 days 
   Impact 5 days 
(Hoffmann & Schmelz, 
1999) 
      
 UVB Forearm Thermode 3 days (Benrath et al., 2001) 
   Mechanical 5 days  
      
 UVB Upper leg Electrical ≥ 2days (Gustorff et al., 2004a) 
   Thermal ≥ 2days  
   Mechanical ≥ 2days  
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Hyperalgesia after UVA-light irradiation was not confined to noxious thermal 
challenges. In their initial description of the UVA model, Perkins and Campbell 
(1992), concentrated on describing the thermal hyperalgesia and only briefly 
mentioned that mechanical hyperalgesia was present (Perkins et al., 1992). However, 
others have shown that mechanical hyperalgesia and allodynia are induced by 
exposure of the rat hindpaw to UVA-light (Boxall et al., 1998; Davies et al., 2005).  
 
Mechanical hyperalgesia developed within 2 to 12 hours, after UVA-light exposure, 
and resolved within four to five days (Boxall et al., 1998; Davies et al., 2005). 
However, the onset and duration of allodynia was different to those of hyperalgesia 
(Davies et al., 2005). von Frey hairs generating 8g and 15g of force applied to rat 
hindpaws evoked hyperalgesia, in UVA-light exposed paws, within 12 hours of UVA-
light exposure, with the hyperalgesia lasting five days. In contrast allodynia, in UVA-
light exposed paws, to von Frey hairs generating 2g and 4g of force appeared only 36-
48 hours after UVA irradiation, and lasted for four days. There was no explanation as 
to why there should be such discrepancies in the rats’ response to the mechanical 
challenges. Cold allodynia also was present after UVA-light exposure of the rat hind 
paw (Davies et al., 2005). Cold allodynia, as assessed by the acetone drop test, 
presented within six hours and lasted for three days after UVA-light exposure (Davies 
et al., 2005). Therefore in rats, exposure of the rat hindpaw to UVA-light causes a 
reliable and easily reproducible thermal hyperalgesia, mechanical hyperalgesia, 
mechanical allodynia and cold allodynia, and the duration and peak of hyperalgesia 
depended on the noxious challenge modality used.   
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In humans, UVA-light induced thermal and mechanical hyperalgesia has been 
described only once (Harrison et al., 2004). Exposure of buttock skin produced 
thermal and mechanical hyperalgesia that peaked two days after UVA-light exposure 
and had resolved by three days (Harrison et al., 2004).  However, most studies have 
found that UVA-light caused erythema and tanning but not hyperalgesia in humans 
(Bickel et al., 1998; Hoffmann & Schmelz, 1999).  
 
UVB-light also has been used as a conditioning event in behavioural studies of 
nociception in rats (Hamilton et al., 1999; Bishop et al., 2007), mice (Saade et al., 
2000) and humans (see below). In rats, UVB-light exposure of rat hind paw dorsal and 
plantar surfaces caused thermal hyperalgesia and mechanical allodynia in the paw 
exposed to UVB-light (Hamilton et al., 1999; Bishop et al., 2007). The duration and 
severity of the thermal hyperalgesia and mechanical allodynia were dose dependant, 
with higher doses causing longer and more severe thermal hyperalgesia and 
mechanical allodynia. However, the peak severity of thermal hyperalgesia and 
mechanical allodynia, at all doses tested, was reached after two days (Bishop et al., 
2007). Thermal hyperalgesia and mechanical allodynia lasted for seven and ten days 
respectively, after exposure to UVB-light at the highest dose (Bishop et al., 2007).  
 
UVB-light irradiation of the backs of the mice, as opposed to rats, produced thermal 
hyperalgesia at anatomical sites distant from the site of UVB-light exposure, and a 
differing time course of hyperalgesia (Saade et al., 2000). After the backs of mice 
were irradiated with UVB-light at different doses, there was a dose-dependant 
decrease in the paw hot-plate test and tail-flick test response latencies. The time-
course of the hyperalgesia displayed a biphasic response, as opposed to a monopahsic 
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response that occurred after UVB-light exposure of the rat hind paw (Hamilton et al., 
1999; Bishop et al., 2007), with an initial phase that peaked at 3-6 hours after 
exposure, and a late phase that peaked 48-96 hours after exposure.  
 
UVB-light irradiation of human skin causes a dose-dependant hyperalgesia to noxious 
mechanical and thermal challenges (Bickel et al., 1998; Hoffmann & Schmelz, 1999; 
Koppert et al., 1999; Benrath et al., 2001; Sycha et al., 2003; Gustorff et al., 2004a; 
Gustorff et al., 2004b; Harrison et al., 2004; Koppert et al., 2004; Sycha et al., 2005; 
Sycha et al., 2006). Hyperalgesia to noxious mechanical and thermal challenges 
develops in a dose-dependant manner, with higher doses of UVB-light causing more 
severe and prolonged hyperalgesia. The hyperalgesia for the thermal and mechanical 
challenge modalities lasted from four to nine days, depending on the body area 
irradiated, with a peak reached between one and two days post-irradiation (Hoffmann 
& Schmelz, 1999; Benrath et al., 2001).  
 
Therefore, in rodents and humans, exposure to UVB-light caused thermal and 
mechanical hyperalgesia and allodynia. Exposure of the rat hindpaw caused thermal 
hyperalgesia and mechanical allodynia that lasted for seven and ten days respectively. 
In mice, exposure of their dorsal surface caused a secondary thermal hyperalgesia. 
The time course of the hyperalgesia was biphasic, with an initial phase, which peaked 
at 3-6 hours after exposure, and a late phase, which peaked 48-96 hours after UVB-
light exposure. In humans thermal and mechanical hyperalgesia peaked three days 
after to UVB-light exposure and lasted for four to nine days. In human studies the 
peak and duration of hyperalgesia differed due to variation in dose and body sites 
used.  
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1.2.2 Pharmacology of UV-light induced hyperalgesia 
 
Different pharmacological agents have been used in an attempt to characterise 
hyperalgesia caused by UVA-light and UVB-light (Table 2). I have divided the agents 
under separate headings and highlighted the major findings for each agent. 
 
1.2.2.1 Opioids 
 
Morphine, the gold-standard analgesic, injected subcutaneously produced a dose-
related, and naloxone-reversible, increase in response latencies to a noxious thermal 
one and five days after UVA-light exposure of rat hind-paws (Perkins et al., 1992). 
The investigators did not measure motor responses of the rats at the doses of 
morphine they used, and it was unclear whether the increase in response latencies was 
due to analgesia or sedation of the rats (Cartmell et al., 1991). Morphine also 
significantly reversed, in a dose-dependant manner, thermal and mechanical 
hyperalgesia after UVB-light exposure of the rat hind paw (Bishop et al., 2007). 
Loperamide, a peripheral µ opioid receptor agonist that does not cross the blood brain 
barrier, reversed thermal and mechanical hyperalgesia after UVB-light exposure of the 
rat hind paw, in a dose-dependant manner (Bishop et al., 2007). Therefore, 
morphine’s analgesia may have been mediated solely through activation of peripheral, 
and not central, µ opioid receptors.  
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Table 2: Effect of pharmacological interventions on UV-light induced hyperalgesia 
 
Pharmacological 
intervention 
Effect on 
hyperalgesia Species 
Light 
wavelength 
Site 
irradiated 
Route of 
administration Noxious challenge Reference 
        
Systemic 
morphine Reduced Rats UVA Hindpaw Subcutaneous Thermal (Perkins et al., 1993) 
 Reduced Rats UVB Hindpaw Not stated 
 
Thermal 
Mechanical 
(Bishop et al., 2007) 
        
Regional 
morphine Reduced Humans UVB Upper leg Intravenous 
 
Thermal 
Mechanical 
(Koppert et al., 
1999) 
        
Remifentanil Reduced Humans UVB Upper leg Intravenous 
 
Thermal 
Mechanical 
(Gustorff et al., 
2004b) 
        
κ-agonist 
(EMD61753) No effect Humans UVB Upper leg Oral Thermal (Bickel et al., 1998) 
        
Loperamide – 
peripheral µ 
opioid receptor 
agonist 
Reduced Rats UVB Hindpaw Not stated 
 
Thermal 
Mechanical 
(Bishop et al., 2007) 
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Pharmacological 
intervention 
Effect on 
hyperalgesia Species 
Light 
wavelength 
Site 
irradiated 
Route of 
admnistration Noxious challenge Reference 
        
Systemic 
ibuprofen-non 
selective COX 
inhibitor 
Reduced Rats UVB Hindpaw Subcutaneous Thermal 
(Perkins et al., 
1993) 
 Reduced Rats UVB Hindpaw Not stated 
 
Thermal 
Mechanical 
(Bishop et al., 2007) 
 Reduced Humans UVB Upper leg Oral 
 
Thermal 
Mechanical 
(Bickel et al., 1998) 
        
 Reduced Humans UVB Upper leg Oral Thermal (Sycha et al., 2003) 
        
Topical 
ibuprofen Reduced Rats UVB Hindpaw Gel on hindpaw 
 
Thermal 
Mechanical 
(Bishop et al., 2007) 
Rofecoxib-COX 
2 inhibitor Reduced Humans UVB Upper leg 
Oral 
 
Thermal 
Mechanical 
(Sycha et al., 2005) 
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Pharmacological 
intervention 
Effect on 
hyperalgesia Species 
Light 
wavelength 
Site 
irradiated 
Route of 
administration Noxious challenge Reference 
        
Bradykinin 
agonists 
 
       
Bradykinin Enhanced Rats UVA Hindpaw Intravenous Thermal 
(Perkins & Kelly, 
1993) 
B1 receptor Enhanced Rats UVA Hindpaw Intravenous Thermal 
(Perkins & Kelly, 
1993) 
 Enhanced Rats UVA Hindpaw Intravenous Thermal (Perkins et al., 1993) 
 Enhanced Humans UVB Thigh Intracutaneously Pain intensities 
(Eisenbarth et al., 
2004) 
B2 receptor Enhanced Humans UVB Thigh Intracutaneously 
 
Pain intensities 
 
(Eisenbarth et al., 
2004) 
        
Bradykinin 
antagonists 
 
       
 
B1 receptor 
 
Reduced Rats UVA Hindpaw Intraplantar Thermal (Perkins et al., 1993) 
B2 receptor No effect Rats UVA Hindpaw Subcutaneous Thermal (Perkins et al., 1993) 
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Pharmacological 
intervention 
Effect on 
hyperalgesia Species 
Light 
wavelength 
Site 
irradiated 
Route of 
administration Noxious challenge Reference 
        
ATP Enhanced Rats UVB Hindpaw Intraplantar Thermal 
(Hamilton et al., 
1999) 
 Enhanced Humans UVB Forearm Intracutaneously Pain intensities 
(Hamilton et al., 
2000) 
        
IL-10 and IL-13 Reduced Mice UVB 
Dorsal 
surface Intra-peritoneal Thermal (Saade et al., 2000) 
        
Lidocaine- 
sodium channel 
antagonist 
Reduced Humans UVB Upper leg Intravenous Mechanical 
(Koppert et al., 
2004) 
        
Gabapentin No effect Humans UVB Upper leg Oral 
Thermal 
Mechanical 
(Gustorff et al., 
2004b) 
        
Botulinum toxin No effect Humans UVB Upper leg Intracutaneously 
Thermal 
Mechanical (Sycha et al., 2006) 
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In humans, opioid agonists administered systemically or regionally, reversed UVB-
light induced thermal hyperalgesia (Koppert et al., 1999; Gustorff et al., 2004b).  
When administered regionally the extremity, usually the arm, is elevated and 
exanguinated by tightly wrapping bandages in a proximal to distal direction. The 
opioid agonist is then injected intravenously to anaesthetise the arm. Remifentanil, a 
potent synthetic opioid agonist, injected intravenously reversed thermal hyperalgesia 
and secondary mechanical hyperalgesia after UVB-light exposure of the upper leg 
(Gustorff et al., 2004b). Morphine injected locally, via intravenous regional 
anesthesia, after UVB-light irradiation of the upper leg, abolished thermal 
hyperalgesia, but not mechanical hyperalgesia at UVB-light exposed areas (Koppert et 
al., 1999). As plasma levels of morphine were very low, morphine probably 
attenuated thermal hyperalgesia, but not mechanical hyperalgesia, by a peripheral 
mode of action, which implies inhibition of effector pathways leading to heat, but not 
mechanical, sensitization. Therefore, UVB-light may sensitize peripheral afferent 
neurons to noxious thermal but not mechanical challenges. Morphine probably acted 
through µ opioid receptors, as oral administration of κ-selective agonists did not 
reduce thermal or mechanical hyperalgesia in humans after UVB-light irradiation of 
the upper leg (Bickel et al., 1998).  
 
1.2.2.2 Eicosanoids 
 
Eicosanoids are arachadonic acid metabolites that include prostaglandins, 
prostacyclins, thromboxanes and leukotrienes. They sensitize nociceptors to 
endogenous and exogenous compounds (McMahon et al., 2005). Prostaglandins 
sensitize nociceptors by reducing the activation threshold of voltage sensitive 
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tetrodotoxin-resistant sodium channels specific to nociceptors, increasing intracellular 
cyclic AMP levels, and increasing the excitability of nociceptive neurones (McMahon 
et al., 2005).  
 
Ibuprofen, a non-selective COX-inhibitor, reversed thermal hyperalgesia when 
injected subcutaneously one day after UVA-light exposure of the rat hind-paw, but 
was significantly less effective when given five days after exposure (Perkins et al., 
1992). Therefore, prostaglandins may be responsible for initiating hyperalgesia but 
not maintaining hyperalgesia after UVA-light exposure. Such a finding contrasts with 
the lack of efficacy of COX inhibitors in erythema induced by UVA-light. It is 
possible that prostaglandins are involved in hyperalgesia but not erythema after UVA-
light exposure. Since COX-2 inhibitors have not been used in models of UVA-light 
induced hyperalgesia, no information was available as to whether COX-1 or COX-2 
(or both) are responsible for prostaglandin synthesis after UVA-light exposure. 
 
Systemic and locally applied ibuprofen also reversed thermal hyperalgesia and 
mechanical allodynia after UVB-light exposure of the rat hindpaw (Bishop et al., 
2007).  When administered two days after UVB-light exposure, systemic and local 
administered ibuprofen produced a dose dependant reversal of thermal hyperalgesia 
and mechanical allodynia (Bishop et al., 2007).  Ibuprofen, ingested before UVB-light 
exposure of human skin, also significantly decreased heat and mechanical 
hyperalgesia caused by UVB-light exposure, but it had no effect on responses obtained 
from applying the same noxious challenge to skin not exposed to UVB-light (Bickel et 
al., 1998; Sycha et al., 2003).  
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The majority of COX inhibitors inhibit both COX-1 and COX-2. Therefore, unless 
selective inhibitors are used, it is difficult to determine the relative importance of each 
enzyme in hyperalgesia caused by UV-light.  Rofecoxib, a COX-2 selective inhibitor, 
taken orally before UVB-light exposure, significantly reduced thermal hyperalgesia, 
superficial skin blood flow and the area of secondary hyperalgesia caused by UVB-
light irradiation of human skin (Sycha et al., 2005). Hence, the study suggests that 
COX-2, not COX-1, was responsible for prostaglandin synthesis after human UVB-
light exposure. Injury after UVB-light exposure was consistent with an inflammatory 
model of hyperalgesia, whereby COX enzymes are upregulated and prostaglandins 
synthesized in response to an inflammatory conditioning event. Since rofecoxib and 
ibuprofen were administered systemically, their site of action in the neuraxis was 
unknown, but since rofecoxib reduced the area of secondary hyperalgesia, it was 
possible that rofecoxib altered prostaglandin production within the central nervous 
system. However, it could be that inhibiting peripheral prostaglandin production 
prevented central sensitization.  
 
1.2.2.3 Bradykinin 
 
Bradykinin is an endogenous algogen that is released after tissue injury. It can activate 
nociceptors directly and sensitize nociceptors through activation of phospholipase C, 
protein kinase C, production of arachadonic acid and modulation of TRPV1 channels 
(McMahon et al., 2005). Bradykinin exerts its action through B1 and B2 receptors 
(McMahon et al., 2005). B1 receptors are expressed during inflammation and injury, 
and B2 receptors are constitutively expressed. However, B2 receptors do play a role in 
pain during inflammation (McMahon et al., 2005).  
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B1 receptors, not B2 receptors, play a significant role in thermal hyperalgesia after 
UVA-light exposure in rats (Perkins et al., 1993; Perkins & Kelly, 1993). The B1-
receptor agonist des-Arg9-BK, and, surprisingly bradykinin, injected subcutaneously 
into the rat hind paw, had no effect on withdrawal latency to a noxious heat challenge. 
They did not, therefore, sensitize nociceptors to a noxious thermal challenge (Perkins 
& Kelly, 1993). However, when given after UVA-light exposure both agents 
exacerbated thermal hyperalgesia in the exposed paw (Perkins & Kelly, 1993). In 
addition, polymodal C-fibre receptor activity was increased when bradykinin was 
administered after UV-light (no wavelength stated) irradiation of the rabbit ear 
(Szolcsanyi, 1987). Therefore, UV-light sensitized animal tissue to the effects of 
bradykinin receptor agonists. The hyperalgesic actions of des-Arg9-BK and 
bradykinin, after UVA-light exposure of the rat hindpaw, were reduced by the B1 
receptor antagonist des-Arg9, Leu8-BK, but not by the B2 receptor antagonist HOE 
140 (Perkins & Kelly, 1993). In another study, B1 and B2 receptor antagonists 
attenuated thermal hyperalgesia after UVA-light irradiation of the rat hindpaw. 
However, there was a clear difference in the efficacy of the two antagonists with des-
Arg9, Leu8-BK, a B1 receptor antagonist, being more effective than HOE 140, a B2 
receptor antagonist. Only repeated administrations of HOE 140 was effective and 
HOE 140 increased the paw withdrawal latencies by 35%, while des-Arg9, Leu8-Bk 
increased paw withdrawal latencies by up to 85% (Perkins et al., 1993). The reduction 
of des-Arg9-BK induced hyperalgesia by a B1 receptor, but not a B2 receptor 
antagonist implies that des-Arg9-BK was activating B1 receptors that were not 
normally present as des-Arg9-BK was inactive in naïve animals. Therefore, UVA-light 
exposure induced B1 receptor expression but not B2 receptor expression. 
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In humans, only one study has investigated the role of bradykinin receptors in 
hyperalgesia induced by UVB-light (Eisenbarth et al., 2004), and their role in 
hyperalgesia induced by UVA-light in humans has not been investigated.  The B1 
receptor agonist, des-Arg10-kallidin, and bradykinin, presumed to be a B2 receptor 
agonist, were injected into the dermis before and after UVB-light irradiation of ventral 
thigh skin, and pain, vasodilatation, protein extravasation, and axon reflex 
vasodilatation were measured (Eisenbarth et al., 2004). UVB-light exposure of ventral 
thigh skin enhanced des-Arg10-kallidin and bradykinin mediated pain, but UVB-light 
exposure enhanced only des-Arg10-kallidin mediated local vasodilatation and had no 
effect on bradykinin mediated local vasodilatation (Eisenbarth et al., 2004). Protein 
extravasation was not enhanced by UVB-light exposure, so neuronal and vascular 
responses were differentially sensitized. Although a novel study, there were anomalies 
in the study that precluded definitive interpretation of the study’s findings. First, 
bradykinin was used as a B2 receptor agonist, but bradykinin acts at both B1 and B2 
receptors. Secondly, it was stated that the pain responses to bradykinin injection were 
elevated significantly; but post-hoc statistical tests did not indicate significance.  
 
1.2.2.4 ATP 
 
After tissue injury ATP is released into the extracellular tissues and activates C-fibre 
nociceptors, but it does not sensitize nociceptors to thermal nor mechanical 
challenges, and activates only capsaicin-sensitive neurones (Hamilton et al., 1999; 
Hamilton et al., 2000).  Receptors for ATP have been found on primary sensory 
afferents both on the dorsal root ganglion and in the periphery. ATP activates 
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nociceptive neurones in normal skin via the P2X3 receptor and the heteromeric P2X2-
P2X3 receptor (McMahon et al., 2005).  
 
In rats (Hamilton et al., 1999) and humans (Hamilton et al., 2000) intradermal 
injection of ATP caused nociceptive responses (rats) and pain (humans). Intradermal 
injection of ATP and its analogues into the hindpaw of rats, in the absence of 
inflammation, produced a dose-dependant increase in hindpaw lifting and a decrease 
in withdrawal latencies to thermal challenge (Hamilton et al., 1999). Therefore, in the 
absence of inflammation ATP is a potent algesic compound (Hamilton et al., 1999). 
In the presence of inflammation, caused by UVB-light exposure, or intradermal 
injection of carrageenan or PGE2, animals’ nociceptive responses to ATP and its 
analogues were augmented (Hamilton et al., 1999). Similarly, in humans intradermal 
injection of ATP caused moderately severe pain (Hamilton et al., 2000), and pre-
treatment of the skin with UVB-light doubled the pain felt after ATP intradermal 
injection, an effect that lasts for 24 hours (Hamilton et al., 2000). The mechanisms for 
this enhanced response to ATP in the presence of inflammation were unclear, but it 
may be through the upregulation of the P2X3 receptor.  
 
1.2.2.5 Nerve growth factor and pro-inflammatory cytokines 
 
Nerve growth factor (NGF) and pro-inflammatory cytokines contribute to 
inflammatory hyperalgesia through direct and indirect mechanisms (Poole et al., 
1999; Sommer, 2001; Koltzenburg, 2004; Sommer & Kress, 2004). NGF contributes 
to inflammatory hyperalgesia by sensitizing peripheral nociceptors to noxious thermal 
challenges, with a subsequent increase in spontaneous polymodal receptor activity 
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and increased nociceptor discharge to noxious thermal challenges (Koltzenburg, 
2004). There is no evidence that NGF sensitizes peripheral nociceptors to noxious 
mechanical challenges. NGF indirectly contributes to inflammatory hyperalgesia by 
causing the release of serotonin and bradykinin from mast cells in the periphery and 
altering sensitivity of neurons to other algogenic agents such as bradykinin and 
capsaicin (Koltzenburg, 2004). The pro-inflammatory cytokines TNF-α, IL-1β, IL-6, 
and cytokine-induced neutrophil chemoattractant (CINC) –1 are upregulated in rat 
models of inflammatory pain and neuropathic pain (Poole et al., 1999; Sommer, 2001; 
Lorenzetti et al., 2002; Sommer & Kress, 2004). The cytokines are upregulated both 
at the site of injury and within the spinal cord (Sommer, 2001). Upregulated pro-
inflammatory cytokines mediate hyperalgesia by either directly sensitizing 
nociceptors or activating a cytokine cascade (Poole et al., 1999; Sommer, 2001; 
Sommer & Kress, 2004). TNF-α induces the production of IL-6 which in turn induces 
IL-1β, with IL-1β activating COX-2 dependant prostaglandin release (Poole et al., 
1999). TNF-α also induces CINC-1 production, which in turn causes the release of 
catecholamines from sympathetic fibres (Poole et al., 1999). 
 
NGF and pro-inflammatory cytokines are increased after UVB-light exposure 
(Gillardon et al., 1995; Saade et al., 2000). NGF and pro-inflammatory cytokines 
have not been measured after exposure to UVA-light. UVB-light exposure of the rat 
hind paw (Gillardon et al., 1995) and the dorsal surface of mice (Saade et al., 2000) 
caused an accumulation of nerve growth factor within the epidermis. NGF was 
concentrated within epidermal keratinocytes and in the cells of the underlying dermis 
(Gillardon et al., 1995). UVB -light irradiation of the back of mice at different doses 
caused a dose-dependant decrease in response latencies in hot plate and tail-flick tests 
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(Saade et al., 2000). Coinciding with this secondary hyperalgesia, exposure to the 
highest dose of UVB-light caused an increase in the pro-inflammatory cytokines IL-
1β, TNF-α, and NGF. Daily treatment of mice with intra-peritoneal injections of the 
anti-inflammatory cytokines IL-10 and IL-13 caused a dose-dependant attenuation of 
the UVB-light induced secondary thermal hyperalgesia, with a parallel decrease in the 
concentrations of IL-1β, TBF-α and NGF (Saade et al., 2000).  Similarly, systemic 
sequestration of NGF through subcutaneous injection of TrkAd5 decreased primary 
and secondary thermal hyperalgesia and mechanical allodynia after UVB-light 
irradiation of the rat hind paw (Bishop et al., 2007).  
 
Therefore, NGF and pro-inflammatory cytokines are involved in secondary thermal 
hyperalgesia and NGF was further involved in mechanical allodynia caused by UVB-
light exposure. Since secondary thermal hyperalgesia and mechanical allodynia are 
produced by central sensitization, it was possible that pro-inflammatory cytokines and 
NGF were acting within the central nervous system to produce their effects.  
 
Up to this point I have focused on the peripheral changes that occur locally at the site 
of UV-light exposure. I have included a brief section describing all the studies that 
inlcude investigations exploring receptors within the spinal cord. Because of the 
paucity of studies, the following sections provide a comprehensive overview of 
changes within the spinal cord after UV-light exposure. 
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 1.2.2.6 Glutamate receptors 
 
Metabotropic glutamate receptors (mGluRs) are a family of G-protein couple 
receptors that modulate nociceptive processing within the peripheral and central 
nervous system (for an extensive review see Neugebauer 2002). There are eight 
subtypes of metabotropic glutamate receptors, mGluR 1-8, divided into three groups, 
group 1 (mGluR 1,5), group II (mGluR 2,3) and group III (mGluR 4,6,7,8), and 
receptors from different groups have a different role in nociceptive processing. 
Activation of group I mGluRs contribute to peripheral and central sensitization, while 
activation of group II mGluRs reduces peripheral and central sensitization 
(Neugebauer, 2002). The role of group III mGluRs in nociceptive transmission 
remains unclear. 
 
UVA-light exposure of the rat hind paw caused a significant increase in the expression 
of mGluR 3 mRNA within the cells of the dorsal laminae in both sides of the lumbar 
spinal cord (Boxall et al., 1998). The increase was most pronounced in laminae II, III 
and IV, and gradually decreased and disappeared by the third day after UVA-light 
irradiation. In parallel with these changes in mRNA, behavioural experiments 
revealed mechanical hyperalgesia in both hindpaws after UVA-light exposure. No 
changes were detected in the levels of expression of mGluR 1,2,4,5,7 subtype mRNA 
in spinal cords taken from hyperalgesic animals and no changes were noted in mRNA 
for any of the glutamate receptors in thoracic segments (Boxall et al., 1998). The 
significance of this finding is unclear, as mGluR mRNA increase does not necessarily 
mean an increase of mGluR within cell membranes, nor does it prove an increase in 
neuronal hyperexcitability within the spinal cord. Furthermore, correlating mRNA 
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changes with behavioural changes does not prove causality. A reversal of behavioural 
hyperalgesia with a concomitant reversal of mRNA expression would have proven 
more definitive. The absence of an increase in mRNA expression for the other mGluR 
does not preclude their role in UVA-light induced hyperalgesia. Thus the study by 
Boxall et al. (1988) does not provide any definitive answers for the role of mGluRs in 
UVA-light induced hyperalgesia. 
 
1.2.2.7 Proto-oncogenes 
 
The proto-oncogenes c-fos and junD produce immunologically detectable nuclear 
proteins Fos and JUND. Different spatial and temporal patterns of proto-oncogene 
expression, especially c-fos and its product Fos, in spinal neurones have been reported 
in response to various peripheral noxious and inflammatory stimuli (Coggeshall, 
2005). Fos and c-fos are expressed rapidly in central nervous system neurones after 
noxious challenges and their expression identifies those neurones activated by a 
nociceptive challenge (Coggeshall, 2005). The physiological functions of these proto-
oncogenes and their products are unknown. Their main contribution is as an efficient 
tool to delineate anatomical organisation of nociceptive systems (Coggeshall, 2005).   
In addition, changes in noxious challenge intensity and duration alter Fos expression, 
thus Fos can be used to assess functioning of dorsal horn neurones, particularly in 
response to pharmacological agents (Coggeshall, 2005). 
 
UVB-light exposure of the rat hind paw did not increase c-fos expression in the spinal 
cord laminae I and II (Bishop et al., 2007). However, thermally evoked c-fos 
expression within laminae I and II was enhanced after UVB-light exposure (Bishop et 
 36 
al., 2007). The absence of an increase in basal c-fos expression after UVB-light 
exposure implies that UVB-light exposure does not cause ongoing afferent activity 
within the irradiated area, but that UVB-light exposure may sensitize peripheral 
nociceptors such that there was increased activation of nociceptive pathways in 
response to noxious thermal challenge after UVB-light exposure. Since this postulate 
requires electrophysiological recordings to confirm its veracity, any conclusions 
reached from c-fos and Fos expression regarding neurophysiological changes within 
the spinal cord after UVB-light irradiation are speculative.  
 
UVB-light exposure of the right hind paw increased the levels of junD mRNA in the 
ipsilateral half of the lumbar spinal cord (Gillardon et al., 1992b). The increase in 
junD mRNA was paralleled by an increase in JUND protein levels in ipsilateral dorsal 
root ganglion neurones. Increased labelling of junD mRNA occurred in large and 
small diameter neurones (Gillardon et al., 1995). As with c-fos and Fos the 
physiological relevance of an increase of junD mRNA and JUND in contributing to 
UVB-light induced hyperalgesia is unknown.  
 
In summary, significantly fewer studies have investigated the biochemical changes, 
related to nociception, after UVA-light than after UVB-light exposure. The systemic 
administration of morphine, ibuprofen, a COX inhibitor, and bradykinin antagonists 
reversed UVA-light induced hyperalgesia. It seems that prostaglandins are involved in 
initiating but not maintaining UVA-light induced hyperalgesia. In addition, bradykinin 
B1 receptors are upregulated and sensitized after UVA-light exposure. Metabotropic 
glutamate receptor mRNA in spinal cord lamina was increased after UVA-light 
exposure. However, there are no data that demonstrate an increase in glutamate 
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receptor number or altered sensitivity to glutamate, and the physiological significance 
of increased metabotropic glutamate receptor mRNA is thus unknown.  
 
As with UVA-light exposure, morphine reversed hyperalgesia after UVB-light 
exposure, and morphine’s analgesia may have been mediated through activation of 
peripheral, and not central, µ opioid receptors. In addition, regional administration of 
opioids abolished thermal hyperalgesia but not mechanical hyperalgesia after UVB-
light exposure, which suggests that UVB-light sensitizes peripheral afferent neurones 
to noxious thermal, but not mechanical, challenges. The administration of COX-1 and 
COX-2 inhibitors reversed hyperaemia, and primary and secondary hyperalgesia after 
UVB-light exposure. Therefore, injury after UVB-light irradiation was consistent with 
an inflammatory model of hyperalgesia, whereby COX enzymes are upregulated and 
prostaglandins synthesized in response to an inflammatory conditioning event. UVB-
light exposure enhanced nociceptive responses to ATP and its analogues. The 
mechanisms for this enhanced response to ATP were unclear, but it may be through 
the upregulation of the ATP receptor P2X3. UVB-light caused an increase in the 
synthesis the proto-oncogenes c-fos and junD mRNA and their protein products Fos 
and JUND. The physiological relevance of an increase of proto-oncogenes and their 
protein products in contributing to UVB-light induced hyperalgesia is unknown. NGF 
and pro-inflammatory cytokines are increased after UVB-light exposure, and UVB-
light hyperalgesia can be reduced by anti-inflammatory cytokines. NGF and pro-
inflammatory cytokines contribute to secondary thermal hyperalgesia, and NGF 
further contributes to mechanical allodynia after UVB-light exposure. Since secondary 
thermal hyperalgesia and mechanical allodynia are produced by central sensitization it 
is possible that pro-inflammatory cytokines and NGF act within the central nervous 
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system to produce their effects. There is therefore ample biochemical evidence that 
UVB-light causes an inflammatory hyperalgesia, with a paucity of evidence that UVA-
light causes an inflammatory hyperalgesia. 
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1.2.3 Electrophysiology of UV-induced hyperalgesia 
 
Polymodal receptors, which are quiescent in normal skin became spontaneously 
active after UV-light (spectrum not stated) exposure of rabbit ears (Szolcsanyi, 1987) 
and UVA-light exposure of rat hind paws (Andreev et al., 1994). Also, capsaicin-
induced activation of polymodal receptors was enhanced after UVA-light pre-
treatment. Direct administration of morphine, DAGOL (a µ receptor agonist) and U-
69593 (a κ receptor agonist) but not DPDPE (a δ receptor agonist) to the receptive 
field of UVA-light irradiated neurones produced a concentration-related and naloxone-
reversible suppression of spontaneous firing in polymodal receptors of UVA-light 
exposed skin (Andreev et al., 1994). Therefore, polymodal receptors changed their 
activity and sensitivity to exogenous opioids after the induction of peripheral 
hyperalgesia by UVA-light exposure, and this hypersensitivity was attenuated by µ 
and κ opioid receptor antagonists (Andreev et al., 1994). Increased peripheral 
neuronal hyperexcitability occurs after exposure of rat hind paw (Eschenfelder et al., 
1995) and pig skin (Rukwied et al., 2008) to UVB-light. UVB-light exposure of rat 
hind paw, with recordings from C-fibres innervating the hindpaw skin showed long-
lasting low-frequency (0.8-1.25 Hz) spontaneous activity, and the number of 
spontaneously-active C-fibres increased from 0% to 35.3% of the total population of 
C-fibres 72 hours after UVB-light exposure. This rise in the number of spontaneously- 
active C-fibres was evident 24 hours after UVB-light exposure (Eschenfelder et al., 
1995).   
 
Coinciding with the peripheral neuronal hyperexcitability are changes within the 
central nervous system. For example, the proportion of spontaneously-active wide 
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dynamic range (WDR) neurones was increased after UVA-light exposure of the rat 
hindpaw, and the degree of spontaneous activity was enhanced during the time course 
of the hyperalgesia (Urban et al., 1993). The WDR neurones showed a significant 
increase in the total number of spikes and the duration of responses when evoked by 
von Frey stimulation at 15mN, noxious pinch, noxious radiant heat and water heated 
to 52°C, when tested one to three days, and five to seven days after UVA-light 
irradiation (Urban et al., 1993). In addition, the threshold temperature was 
significantly decreased and the average sizes of the receptive fields were expanded 
after UVA-light exposure. To distinguish between possible central and peripheral 
components of the hyperactivity of WDR cells, dorsal rhizotomies were performed 
during the recordings. Cutting L2-3 dorsal roots evoked a larger and more prolonged 
discharge in WDR cells in the rats hindpaws exposed to UVA-light (Urban et al., 
1993). Spontaneous activity over one to three days after UVA-light exposure was 
reduced after the dorsal rhizotomy. However, dorsal rhizotomy had no effect on the 
spontaneous activity of WDR neurones five to seven days after UVA-light exposure. 
Responses to supramaximal electrical stimulation of the rat hind paws also were 
enhanced in the UVA-light exposed rats and once again dorsal rhizotomy reduced the 
number of evoked spikes one to three days after UVA-light exposure but not five to 
seven days after UVA-light exposure. Therefore, UVA-light exposure caused 
prolonged excitability in spinal WDR neurones with enhanced input from primary 
afferents contributing to this increased excitability for the first three days after 
exposure to UVA-light (Urban et al., 1993) 
 
To measure neuronal hyperexcitability within the spinal cord, A- and C-fibre evoked 
VRP (ventral root potentials) were measured in isolated spinal cord preparations that 
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were taken from young rats in which behavioural hyperalgesia (thermal and 
mechanical) had been induced by UVA-light irradiation of the hind paw (Thompson et 
al., 1994). The duration and amplitude of both the A- and C-fibre evoked VRP were 
increased significantly in UVA-light exposed rats. In rats exposed to UVA-light, a 
NMDA receptor antagonist and neurokinin 1 and neurokinin 2 receptor antagonists 
significantly reduced the prolonged VRP evoked by C-fibre stimulation. However, in 
animals not exposed to UVA light, the prolonged VRP evoked by a single shock C-
fibre stimulation was significantly antagonised by a NMDA receptor antagonist and a 
neurokinin 2 receptor antagonist, but not by a neurokinin 1 receptor antagonist, 
implying that neurokinin 1 receptors were altered after UVA-light exposure. Thus, 
enhanced receptor sensitivity of ventral root neurones may contribute to central 
sensitization and may be directly related to behavioural hyperalgesia after UVA-light 
exposure (Thompson et al., 1994). 
 
Another possible mechanism for UVB-light induced hyperalgesia is the activation of 
silent nociceptors (Koppert et al., 2004; Rukwied et al., 2008). The neurogenic axon 
reflex in human skin is mediated by mechanically-insensitive or silent nociceptors, 
and when phasic mechanical stimulation was compared in non-exposed and UVB-light 
exposed skin, the neurogenic flare reaction was present in the irradiated skin but not 
in the non-irradiated skin (Koppert et al., 2004). Systemic lidocaine administration 
suppressed the mechanically induced flare and the mechanical hyperalgesia in UVB-
light exposed skin, while leaving the impact induced ratings in normal skin 
unchanged (Koppert et al., 2004). A similar change of neurogenic axon reflex has 
been observed after UVB-light exposure of pig skin (Rukwied et al., 2008). In pigs, C-
fibre activation was assessed indirectly by axon reflex erythema or the flare response 
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in response to noxious mechanical challenges, von Frey filament exerting 100mN and 
600 mN of pressure, and, noxious thermal challenges, 45°C and 47°C. After UVB-
light exposure of the pig skin, the area of axon reflex erythema was increased in 
response to the various noxious challenges thereby suggesting that peripheral C-fibres 
were sensitized (Rukwied et al., 2008). Data from the above two studies were 
consistent with the sensitization of silent nociceptors.  
 
In summary, UVA-light exposure of rat tissue altered both peripheral nociceptive 
receptors and WDR neurones of the spinal cord. UVA-light increased the spontaneous 
activity of polymodal receptors and spinal WDR neurones, enhanced the response of 
spinal WDR neurones to peripheral noxious challenges, and increased the amplitude 
and duration of VRP. Therefore, UVA-light caused both peripheral nociceptor 
sensitization, increased activation of peripheral nociceptors, and central sensitization, 
enhanced response of dorsal horn cell to peripheral input. UVB-light activated silent 
nociceptors and caused peripheral sensitization. However, no studies have explored 
changes within the central nervous system after UVB-light exposure. 
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1.3 Thesis aims 
 
UV-light induced hyperalgesia is a unique model of hyperalgesia in that it causes 
peripheral and central sensitization through the release of endogenous compounds, 
without necessitating the injection of algogenic substances into animal tissue, such as 
carrageenan into rat hind paw or joints (Hargreaves et al., 1988; Radhakrishnan et al., 
2003), or directly damaging animal tissue, such as nerve ligation or incising rat skin 
(Choi et al., 1994; Brennan et al., 1996; Weber et al., 2005). Almost all current 
animal models of pain and hyperalgesia rely on the above two techniques and, 
although extremely important in the study of chronic pain, are associated with a 
number of problems. For example, the duration of the hyperalgesia is too short for 
anti-hyperalgesic agents to be adequately tested. Ideally anti-hyperalgesics should be 
administered after the hyperalgesia has developed in order to mimic the clinical 
situation, in which anti-hyperalgesics are given only after the patient complains. In 
animal models of sustained hyperalgesia, the experimental animals usually are in 
persistent pain, which in turn causes a constitutive deterioration in their health that 
confounds their responses to nociceptive testing (Blackburn-Munro, 2004). In 
addition, almost none of the procedures can be used in human subjects. The 
conditioning challenges used generally cause irreversible damage to tissue, such as 
nerve ligation, or the conditioning challenge does not cause hyperalgesia in human 
subjects, such as reperfusion hyperalgesia  (unpublished observations).  
 
I believe UV-light induced hyperalgesia offers a solution for the above-mentioned 
problems, in that, in animal models, experimental hyperalgesia is of duration 
sufficient to test anti-hyperalgesic agents without the presence of persistent pain, and 
 44 
UV-light has been used successfully to generate experimental hyperalgesia in human 
subjects. UVB-light causes an inflammatory hyperalgesia that has been successfully 
translated from animal subjects to human subjects (see Table 1 and 2). UVB-light 
causes an increase of pro-inflammatory mediators such as prostaglandins (Black et 
al., 1978a; Black et al., 1980), nitric oxide (Rhodes et al., 2001), and cytokines 
(Oxholm et al., 1988; Kock et al., 1990; Oxholm, 1992; Kondo et al., 1993; 
Strickland et al., 1997; Saade et al., 2000) in exposed tissue, and the histological 
features after UVB-light exposure are consistent with an acute inflammatory response 
(Gilchrest et al., 1981). In addition, hyperalgesia and erythema can be reversed 
successfully through the administration of suitable antagonists, such as COX-1 
(Snyder & Eaglstein, 1974b, a; Black et al., 1978b) and COX-2 (Wilgus et al., 2000; 
Wilgus et al., 2002) inhibitors and nitric oxide synthase inhibitor (Rhodes et al., 
2001). However, the evidence that proves that UVA-light causes a classic 
inflammatory hyperalgesia is not as convincing.  
 
In rats, UVA-light causes an increase in prostaglandins and histamine in skin 
(Gilchrest et al., 1981; Hawk et al., 1983) and the hyperalgesia to UVA-light can be 
reversed with the administration of morphine, ibuprofen (a COX inhibitor), only 
demonstrated in one study (Perkins et al., 1992), and bradykinin antagonists (Perkins 
et al., 1993). Therefore, prostaglandins and bradykinins (both components of the 
inflammatory soup) it would seem are involved in UVA-light induced hyperalgesia. It 
has been assumed therefore that UVA-light causes an inflammatory hyperalgesia in 
rats. However, no studies have examined animal tissue histologically after UVA-light 
exposure to confirm the presence of inflammation. In addition, after exposure to UVA-
light, human tissue exhibits only a mild chronic inflammatory infiltrate within the 
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dermis, very unlike the classic acute inflammatory response observed after UVB-light 
exposure (Kumakiri et al., 1977; Gilchrest et al., 1981). It is therefore possible that 
UVA-light may be causing prolonged hyperalgesia through an inflammation-
independent pathway. If so, UVA-light may offer completely new mechanisms to 
explain prolonged hyperalgesia. I therefore decided to focus my thesis on UVA-light 
hyperalgesia in order to explore whether UVA-light does cause inflammation in rats, 
and to answer several issues that I believe have not been adequately addressed in the 
literature. 
 
In order to study UVA-light induced hyperalgesia, I had to develop my own animal 
model. I have outlined my exposure protocol, and the duration and severity to noxious 
thermal and mechanical challenges in Chapter 2. Although a number of studies have 
been published describing the pathophysiology UVA-light, several issues have not 
been adequately addressed.  For example, in none of the studies published was the 
UV-light spectrum of the UV lamps independently verified. As the nature of light 
changes both with the duration the UV lamps are activated and over the lifespan of 
the UV lamp, it is entirely possible that unwanted light wavelengths may have 
contaminated the UVA-light during animal exposures in previous studies. I 
commissioned experts at the Council for Scientific and Industrial Research, Tshwane, 
South Africa, to measure the spectrum of UV-light emitted by my lamp and I have 
described my findings in Chapter 2. In addition, no studies have examined animal 
tissue to confirm the presence, or absence, of inflammation, and whether 
inflammation does in fact correlate with the behavioural hyperalgesia observed after 
UVA-light exposure. I commissioned a qualified histopathologist to examine, 
histologically, skin tissue removed from the dorsal surface of the rat tail after UVA-
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light exposure to determine the presence of inflammation, and whether inflammation 
correlated with the duration and severity of hyperalgesia. I have described my 
findings in Chapter 2. After I established my model of UVA-light hyperalgesia I 
investigated the neurophysiological basis for the sustained hyperalgesia that UVA-
light caused.  
 
UVA-light increases the spontaneous activity of polymodal receptors and spinal WDR 
neurons (Andreev et al., 1994), enhances the response of spinal WDR neurones to 
peripheral noxious challenges (Urban et al., 1993) and increases the amplitude and 
duration of VRP with possible altered NMDA and neurokinin receptor sensitivity 
(Thompson et al., 1993a). Changes within the WDR neurones may account for UVA-
light induced thermal and mechanical hyperalgesia. The altered WDR activity may 
result from either plasticity in spinal neuronal circuitry after a peripheral insult or 
from changes in primary afferent fibre impulses converging on those spinal neurones 
or both.  To explore the above question I blocked the C-fibre barrage, and also 
recorded the responses of peripheral afferent fibres after UVA-light exposure. 
 
Activation of WDR neurones by C-fibres (C-fibre barrage) during a conditioning 
challenge, causes persistent changes in WDR neurones that far outlasts the duration of 
the conditioning challenge and the C-fibre barrage (Dickenson & Sullivan, 1987; 
Woolf, 1989; Thompson et al., 1993b; Vatine et al., 1998; Ji et al., 2003). The C-fibre 
barrage, as the first step in central sensitization, causes a cascade of reactions that 
ultimately lead to altered excitability of ion channels and membrane-bound receptors 
in WDR cells (Julius & Basbaum, 2001). Consequently, blocking the C-fibre barrage, 
through the administration of a regional local anaesthetic, has attenuated the severity 
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and duration of hyperalgesia in certain animal models of chronic pain (Gonzalez-
Darder et al., 1986; Seltzer et al., 1991). Blocking the C-fibre barrage decreased 
autotomy after sciatic nerve transection (Gonzalez-Darder et al., 1986), and post-
incisional allodynia in rats (Duarte et al., 2005). Since no experiments have 
investigated the role of the C-fibre barrage in UVA-light induced hyperalgesia, I 
decided to block the C-fibre barrage before UVA-light exposure, and record any 
changes in nociceptive testing. I injected bupivacaine, a long-acting local anaesthetic, 
into the base of the rat tail before UVA-light exposure, and then measured the 
behavioural response of animals to noxious thermal and mechanical challenges. I have 
described my findings in Chapter 3. To determine whether sensitization of primary 
afferent nociceptive fibres contributed to mechanical and thermal hyperalgesia after 
UVA-light exposure, I measured the responses of fibres in the rat coccygeal nerve, 
which convey the afferent neuronal activity from the tail, to noxious thermal 
challenges and noxious mechanical challenges after UVA-light exposure of the rat tail. 
I have described my findings in Chapter 4. 
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CHAPTER 2 
 
Exposure of the rat tail to ultraviolet A light produces 
sustained hyperalgesia to noxious thermal and mechanical 
challenges 
 
Themistocleous A, Fick L, du Plessis I, Mitchell B, and 
Mitchell D. (2006). Journal of Neuroscience Methods 152, 
267-273. 
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CHAPTER 3 
 
Pre-emptive ring-block with bupivacaine prevents the 
development of thermal hyperalgesia, but not sustained 
mechanical hyperalgesia, in rat tails exposed to ultraviolet A 
light 
 
Themistocleous A, Kamerman P and Mitchell D. (2007). The 
Journal of Pain 8, 208-214. 
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CHAPTER 4 
 
Discharge patterns of nociceptive primary afferent fibres in 
the rat coccygeal nerve after ultraviolet A light exposure 
 
Themistocleous A, Kamerman P and Mitchell D. (2008) 
Submitted to Journal of Pain. 
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Abstract 
We have shown that administration of the local anaesthetic bupivacaine into the base 
of rats’ tails prevents the development of hyperalgesia induced by UVA-light to a 
noxious thermal challenge, but not to noxious mechanical challenges. The aim of this 
study was to determine whether exposure of rats’ tails to UVA-light altered the 
responses of Aδ- and C-fibres innervating the tail to noxious mechanical and noxious 
thermal challenges. We dissected the right ventral coccygeal nerve in Sprague Dawley 
rats that had had their tails exposed to, or shielded from, UVA-light 24-hours earlier. 
Single afferent Aδ- and C-fibre receptive fields were located and the fibres response 
to noxious blunt (3.9N bar algometer) and punctate (rat toothed forceps) mechanical 
challenges, as well as a noxious thermal (49°C) challenge was measured. In rats 
exposed to UVA-light, the peak firing rates and areas under the curve of post-
challenge histograms of Aδ- and C-fibres were increased when noxious blunt and 
punctate challenges were applied to the rats’ tails. However, the peak firing rate and 
areas under the curve of post-challenge histograms of C-fibres, which were responsive 
to noxious thermal challenges, were not increased after UVA-light exposure. We have 
shown that the Aδ- and C-fibres that encode for noxious punctate and blunt 
challenges were sensitized after UVA-light exposure, but C-fibres responsible for 
encoding noxious thermal challenges were not sensitized by UVA-light exposure. 
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Perspectives: Eexposure of rats’ tails to UVA-light altered the responses of Aδ- and 
C-fibres innervating the tail to noxious mechanical and noxious thermal challenges. 
Aδ- and C-fibres that encode for noxious punctate and blunt challenges were 
sensitized after UVA-light exposure, but C-fibres responsible for encoding noxious 
thermal challenges were not sensitized by UVA-light exposure. 
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Introduction 
 
Ultraviolet (UV)-light exposure of skin causes peripheral and central neuronal 
hyperexcitability. Polymodal receptors, which are quiescent in normal skin became 
spontaneously active after UV-light (spectrum not stated) exposure of rabbit ears 33 
and UVA-light exposure of rat hind paws 1. Similarly to UVA-light, UVB-light 
exposure of the rat hind paw 11 and pig skin 27 caused peripheral neuronal 
hyperexcitability. UVB-light exposure of rat hind paw caused long-lasting low-
frequency spontaneous activity, and increased number of spontaneously-active fibres 
in recordings from C-fibres innervating the hindpaw skin. This rise in the number of 
spontaneously active C-fibres was evident 24 hours after UVB-light exposure and 
lasted for 72 hours 11. In pigs, C-fibre activation, as assessed by axon reflex erythema, 
was increased to noxious thermal and mechanical challenges in skin that had been 
irradiated with UVB-light 27. In humans, as in pigs, UVB-light activated silent 
nociceptors 21. The neurogenic axon reflex in human skin was present in UVB-light 
irradiated skin but not in the non-irradiated skin 21, and systemic lidocaine 
administration suppressed the mechanically induced flare and the mechanical 
hyperalgesia in sunburnt skin, while leaving the impact induced ratings in normal skin 
unchanged 21. 
 
Coinciding with peripheral neuronal hyperexcitability following UV-light exposure 
are changes within the central nervous system 37,40,41. UVA-light caused numerous 
changes within wide dynamic range (WDR) neurones of the spinal cord. The 
sensitized WDR neurones showed increased spontaneous activity, reduced thresholds 
to non-noxious thermal challenges, increased respon
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thermal challenges, and expanded receptive fields 40. Input from primary afferents 
contributed to the increased WDR excitability for the first three days after exposure to 
UVA-light, thereafter WDR neuronal hyperexcitability was entrenched and 
independent of peripheral neuronal input 40. In addition, the duration and amplitude of 
both the A- and C-fibre evoked ventral root potentials (VRP) were increased 
significantly in UVA-light exposed rats 37. In rats exposed to UVA-light, a NMDA 
receptor antagonist, and neurokinin 1 and neurokinin 2 receptor antagonists 
significantly reduced the prolonged VRP evoked by C-fibre stimulation. However, in 
animals not exposed to UVA light, the prolonged VRP evoked by a single shock C-
fibre stimulation was significantly antagonised by a NMDA receptor antagonist and a 
neurokinin 2 receptor antagonist, but not by a neurokinin 1 receptor antagonist, 
implying that functioning or expression of neurokinin 1 receptors were altered after 
UVA-light exposure 37. 
 
The above-mentioned changes within the peripheral and central nervous system may 
account for the behavioural thermal and mechanical hyperalgesia present after UVA-
light exposure of the rat hind paw and rat tail 23,25,35,36,43. The altered WDR neurone 
activity after UV-light exposure may result from plasticity in spinal neuronal circuitry 
following peripheral insult 37,40,42, or from changes in primary afferent fibre impulses 
converging on those spinal neurons 39, or both. 
 
We recently demonstrated that stopping C-fibre activation by administering local 
anaesthetic into the base of the rat tail during UVA-light exposure of the tail, 
prevented the development of thermal but not mechanical hyperalgesia 36. A possible 
explanation for our findings is that central changes within the WDR neurones of the 
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dorsal horn are responsible for thermal hyperalgesia following UVA-light exposure, 
while peripheral neural changes mediate the mechanical hyperalgesia. To determine 
whether sensitization of primary afferent nociceptive fibres contributes to mechanical 
and thermal hyperalgesia after UVA-light exposure, we investigated the responses of 
fibres in the rat coccygeal nerve, which conveys the afferent neuronal activity from 
the tail, to noxious thermal challenges and noxious mechanical challenges after UVA-
light exposure of the rat tail. We measured the behavioural response of the animals to 
the noxious challenges before we dissected and recorded from the rat coccygeal nerve 
to ensure that hyperalgesia was present in rats exposed to the UVA-light. 
 
A previous study has shown that rat coccygeal nerve contains four groups of afferent 
fibres. Aβ-fibres that respond to both brush and pinch of their receptive fields, Aδ-
fibres that respond to pinch, polymodal C-fibres that respond to noxious heat (49°C) 
and pinch, and another group of C-fibres, that are chemosensitive and show increased 
spontaneous activity in the presence of ischaemia and reperfusion. We focused our 
investigation on only those fibres that would most likely encode for challenges to 
which we subjected our rats, namely the Aδ-fibres and the polymodal C-fibres. We 
did not investigate the responses of the Aβ-fibres because they are predominantly 
responsible for encoding information in the non-noxious range and we have not yet 
established the presence of allodynia, enhanced response to non-noxious challenges, 
in our model of UVA-light induced pain.  
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Materials and Methods 
 
Animals 
 
Thirty-five male Sprague-Dawley rats with an initial mass of 200-225g were used. 
Rats were housed two per cage at an ambient temperature of 21-25°C, and a 12:12 
hour light/ dark cycle, lights on at 07:00. Rats had free access to tap water and 
standard rat chow.  All procedures were approved by the Animal Ethics Screening 
Committee of the University of the Witwatersrand (clearance certificate 2005/07/3) 
and complied with the recommendations of the Committee for Research and Ethical 
Issues of the International Association for the Study of Pain 44. 
 
UVA- light source 
 
A double-ended high-pressure metal halide UVA lamp was used as a source of UVA 
light. The lamp had a spectral irradiance of 37 mW.cm-2, with 60 % of the energy 
emitted in the UVA range, 30% in the UVB range and 10% in the UVC range. The 
UVB irradiance only began to increase from 30 seconds after the lamp was turned on. 
Since the maximum time the lamp was turned on while exposing the rats’ tails was 40 
seconds (see experimental procedure), the tail was exposed predominantly to UVA-
light. The UVA-light lamp was housed in a rig and positioned 350mm above the tail. 
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Noxious thermal challenge 
 
The modified tail flick test described by Gelgor et al. 13,14 was used for behavioural 
measurements undertaken to confirm the presence of hyperalgesia to a noxious 
thermal challenge in rats exposed to UVA-light. Rats’ tails were immersed in 29°C 
water for 30 minutes before the first challenge was made, and between challenges, to 
maintain a constant tail-skin temperature and prevent the confounding effects 
variations in tail skin temperature have on tail flick latency 19,38. To apply the noxious 
thermal challenge, we immersed the whole tail into 49°C water, and measured the 
time taken, from immersion of the tail until the first co-ordinated motor response of 
the tail, with a stopwatch 35,36. The average of three measurements, taken at least one-
minute apart, was recorded as the tail-flick latency. To avoid possible tissue damage, 
immersion of rats’ tails in the 49°C water was limited to 30 seconds.  
 
To apply a thermal challenge during electrophysiological recordings in anaesthetised 
rats, a copper thermode heated to 49°C was used to apply the noxious thermal 
challenge. The copper electrode temperature was maintained by placing the electrode 
in a hot water bath at a fixed temperature of 49°C. During electrophysiological 
recordings the copper thermode was placed lightly against the rat tail, and to ensure 
no mechanoreceptors were activated by this light touch, we applied an innocuous 
challenge (brushing the tail with a camel hair brush, with repeated strokes, for a 10 
sec period) to the same area before applying the thermode.   
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Noxious punctate mechanical challenge 
 
For behavioural measurements undertaken to confirm the presence of hyperalgesia to 
a punctate mechanical challenge in rats exposed to UVA-light, an electronic von Frey 
anaesthesiometer was used to apply a noxious mechanical challenge to the tail, as we 
have described previously 36. The von Frey filament was applied 50, 55 and 60mm 
from the base of the tail with uniformly increasing force until the rat exhibited 
aversive behaviours (e.g. pulling away and jumping). At least a one-minute period of 
recovery for the animal was taken between successive measurements. The mean of 
these three measurements was recorded as the noxious aversive pressure. To avoid 
tissue damage the von Frey filament was removed when the pressure reached 400g.  
 
During electrophysiological recordings in anaesthetised rats a rat toothed forceps was 
used to apply the noxious punctate challenge, and we pinched the receptive field with 
serrated forceps (force of 1.7N) for 10 seconds 29-31.  
 
Noxious blunt mechanical challenge 
 
For behavioural measurements undertaken to confirm the presence of hyperalgesia to 
a blunt mechanical challenge in rats exposed to UVA-light, we used a bar algometer to 
apply the noxious mechanical challenge to the tail. The bar algometer consisted of a 
spring-loaded force gauge (Halda, RS, Sweden), connected, via a lever, to a 20 mm 
long steel bar with a diameter of 1.2 mm. The steel bar was placed transversely across 
the tail, at its midpoint and at two separate sites 10mm proximal and distal to the tail 
midpoint, and at a static force of 3.9N. The time from application of the noxious 
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mechanical challenge until the first sign of aversive behaviour (pulling away and 
jumping) was measured with a stopwatch. To avoid tissue damage the bar algometer 
was removed from the tail if the rat failed to respond within 30 seconds. During 
electrophysiological recordings in anaesthetised rats the bar algometer, generating a 
static force of 3.9N, was applied to the receptive field for 10 seconds.  
 
Experimental procedure 
 
UVA-light exposure and all nociceptive testing took place with the rats restrained in 
transparent plastic restrainers that allowed exposure and movement of the tail, but 
restricted movement of the body. Before the start of the experiment, rats were 
habituated to the restrainers for two hours a day on three consecutive days. On 
experimental days, the rats were placed in the restrainers 30 minutes before the start 
of experimentation. For three consecutive days before we exposed the rats’ tails to 
UVA light, we measured response latencies to the noxious thermal and mechanical 
challenges. On the day of UVA-light exposure, the dorsal surface of the rats’ tails was 
exposed to the light eight times for 40 seconds each, with 260 seconds between the 
exposures 35,36. During UVA-light exposure, the tails of 16 rats were covered with 
aluminium foil (to shield the tails from the light), and left that tails of 19 rats 
uncovered. Nociceptive testing was repeated 24 hours after exposure to UVA-light, 
but before animals were anaesthetised for electrophysiologyical recordings, to 
confirm whether exposure to the UVA-light had caused mechanical and thermal 
hyperalgesia. A single investigator (AT) performed the behavioural and 
electrophysiological experiments, and he was blinded as to whether the rats were 
shielded or exposed to the UVA-light. 
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Electrophysiological recording 
 
Anaesthesia in the rats was induced with xylazine-ketamine (1:4, 1 ml.kg-1 I.M.), and 
maintained with 1.5% enflurane (Ethrane, Abbott Laboratories) in 33% oxygen/67% 
nitrous oxide, which was administered via a face mask. The rats breathed 
spontaneously throughout the experiments. Core body temperature was maintained at 
38°C by means of a heating blanket. The right ventral coccygeal nerve was exposed 
close to the tail base and protected from drying in a pool of mineral oil. To facilitate 
dissection a black plastic plate was placed beneath the nerve. Under a dissecting 
microscope, the epi-and perineural sheaths were slit lengthwise, individual fibre 
bundles were cut proximally and small filaments further divided with micro-
dissection scissors (Trident) and insect pins. The small filaments were placed on a 0.2 
mm diameter platinum wire recording electrode (a silver reference electrode was 
placed in the surrounding tissue), and further dissected until impulses from individual 
fibres could be identified by electrical stimulation of the coccygeal nerve. Electrical 
stimulation (Digitimer DS9A) was via two L-shaped stainless-steel needle electrodes, 
which were inserted subcutaneously along the path of the nerve, approximately 40 
mm distal to the recording site. Typical challenges used for searching for single fibres 
were 1 Hz pulses of 0.04-0.06 ms duration at 1-7 V for A fibres and 1 Hz pulses 0.5-
0.7 ms duration at 10-40 V for C fibres. Filaments containing fibres that could not be 
distinguished easily by difference in spike amplitude were rejected, as were filaments 
containing more than five active fibres. Spikes were amplified (Digitimer NL104), 
filtered through a bandpass of 200-1500 Hz, and discriminated using a spike 
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processor (Digitimer D130) connected to a laboratory interface (CED 1401, 
Cambridge Electronic Design) attached to a microcomputer.  
 
Once a single afferent fibre had been isolated with the electrical search challenge, we 
located its receptive field and determined its response to the noxious challenges. We 
located the receptive field depending on the nature of the fibre examined. If it was an 
Aδ-fibre we located the receptive filed with either the noxious pinch challenge or the 
noxious blunt challenge, and if it was C-fibre we located the receptive filed with the 
noxious thermal challenge. If we had not located the receptive field after several 
attempts the procedure was abandoned to prevent damaging the tail through repeated 
noxious challenges. We did not delineate the extent of the receptive field as repeated 
noxious challenges irreversibly damaged the rat tail tissue and the nature of 
challenges applied did not allow us to describe the true extent of the receptive field. 
We then determined the afferent fibre’s responses to noxious thermal and mechanical 
challenges. Noxious thermal stimulation was achieved by applying a copper thermode 
heated to 49°C, noxious punctate challenge was achieved by pinching the receptive 
field with serrated forceps, and noxious blunt challenge was achieved by applying a 
bar algometer to the receptive field for 10 seconds. We took care not to flex the tail 
during the mechanical challenges, because of the profusion of flex-sensitive fibres in 
the nerve 22. Only one of us (AT) applied the challenges, so they were consistent 
throughout the procedure. Areas under the curve and peak firing rates were calculated 
from post challenge time histograms, produced by the computer analysis software, 
that were generated after each noxious challenge. The area under the curve is a 
measure of firing rate over time and was calculated as the total area covered by the 
post challenge histograms. Conduction velocities were also measured from the post 
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challenge time histograms following suprathreshold electrical stimulation of the fibre. 
In some preparations several afferent fibres could be discharged within the same 
filament of nerve, and their responses were characterised individually on the basis of 
their conduction velocities, amplitude and shape of their spikes.  
 
Data analysis 
 
No animals reached the 30-second cut-off time for tail-flick latencies and aversive 
response latencies or the 400g cut-off pressure for the aversive behaviour responses 
during nociceptive testing, allowing the use of parametric statistical analysis. To 
determine whether UVA-light caused hyperalgesia, tail-flick latencies, aversive 
response latencies and aversive pressures, for shielded and exposed rats, were 
compared to each other using a two-way ANOVA and Tukey post-hoc tests. Neural 
responses, peak firing rates and areas under the curve, to noxious thermal, punctate 
and blunt challenges were compared with unpaired t-tests.  
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Results 
 
 
Behavioural response to noxious thermal challenge 
 
 
The effect of UVA-light exposure on tail flick latencies to a 49° thermal challenge is 
shown in Figure 1a. Pre-exposure tail flick latencies were 6.2 ± 1.0s for the group 
destined for UVA-light exposure, and 6.5 ± 1.2s for the group destined to be shielded 
and their pre-exposure latencies did not differ significantly (P > 0.05, two-way 
ANOVA). In the rats with tails that had been exposed to UVA light, one day after UVA 
light exposure tail flick latencies were significantly decreased from their pre-exposure 
tail flick latencies by 25%, to 4.9 ± 1.3s (P < 0.001, two-way ANOVA with Tukey 
post-hoc test). Their tail flick latencies also were significantly lower than the latencies 
of the rats exposed to the UVA-light but with tails shielded, 7.2 ± 1.5s (P < 0.001, 
two-way ANOVA with Tukey post-hoc test). 
 
Behavioural response to noxious punctate mechanical challenge 
 
 
The effect of UVA-light exposure on aversive pressure thresholds is shown in Figure 
1b. Pre-exposure pressures were 265 ± 32g for the group destined for UVA–light 
exposure, and 274 ± 46g for the group destined to be shielded. Their pre-exposure 
pressures did not differ significantly (P > 0.05, two-way ANOVA). In the rats with 
tails that had been exposed to UVA-light one day after UVA-light exposure aversive 
pressure thresholds were significantly decreased from their pre-exposure aversive 
pressure thresholds by 51% to 128 ± 43g (P < 0.001, two-way ANOVA with Tukey 
post-hoc test).  Their aversive pressure thresholds also were significantly lower than 
the thresholds of the rats exposed to the same UVA-light but with tails shielded, 257 ± 
40g (P < 0.001, two-way ANOVA with Tukey post-hoc test). 
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Behavioural response to noxious blunt mechanical challenge 
 
 
The effect of UVA-light exposure on aversive escape latencies to a blunt mechanical 
challenge is shown in Figure 1c. Pre-exposure aversive escape latencies were 11.3 ± 
4.6s for the group destined for UVA-light exposure, and 11.7 ± 3.0 s for the group 
destined to be shielded and their pre-exposure latencies did not differ significantly (P 
> 0.05, two-way ANOVA). In the rats with tails that had been exposed to UVA light 
one day after UVA-light exposure aversive escape latencies were significantly 
decreased from their pre-exposure aversive escape latencies, by 51%, to 5.3 ± 2.8s (P 
< 0.001, two-way ANOVA with Tukey post-hoc test). Their aversive escape latencies 
also were significantly lower than the latencies of the rats exposed to the same UVA-
light but with tails shielded, 10.6 ± 3.0 s (P < 0.001, two-way ANOVA with Tukey 
post-hoc test). 
Electrophysiological recordings 
 
Conduction velocities 
 
The conduction velocities of the Aδ-fibres were 3.4 ±1.2 m/s. The conduction 
velocities of the C-fibres were 0.7±0.3 m/s. Figures 2 and 3, show examples of 
recordings from two Aδ-fibres and two C-fibres, respectively. 
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Neural response to noxious thermal challenge 
 
The effect of UVA-light exposure on C-fibre response to noxious heat is shown in 
Figure 4 and Figure 5. We identified C-fibres that were responsive to a noxious 
thermal challenge in nine exposed animals and 11 shielded animals. Peak firing rate 
of C-fibres for the tails of rats that had been shielded was 47 ± 12 spikes.s-1 and 46 ± 
19 spikes.s-1 for those rats the tails of which had been exposed. Their peak firing rates 
were not significantly different (P = 0.76, unpaired t-test). Area under the curve of C-
fibres for the tails of rats that had been shielded was 146 ± 44 spikes and 157 ± 56 
spikes for those rats the tails of which had been exposed. The areas under the curve 
were not significantly different between groups (P = 0.72, unpaired t-test). 
 
Neural response to noxious punctate mechanical challenge 
 
The effect of UVA-light exposure on Aδ- and C-fibre responses to a noxious punctate 
challenge is shown in Figure 6 and 7. . We identified 7 Aδ-fibres and 6 C-fibres that 
were responsive to a punctate mechanical challenge in rats exposed to UVA-light, and 
8 Aδ-fibres and 8 C-fibres that were responsive to a punctate mechanical challenge in 
rats shielded from UVA-light. Only one type of each fibre was identified in each 
animal. The peak firing rate of Aδ-fibres for the tails of rats which had been shielded 
were 25 ± 14 spikes.s-1 and 48 ± 12 spike.s-1 for those rats the tails of which had been 
exposed. Their peak firing rates were significantly different (P = 0.003, unpaired t-
test). The peak firing rate of C-fibres for the tails of rats which had been shielded was 
19 ± 8 spikes.s-1 and 43 ± 11 spikes.s-1 for those rats the tails of which had been 
exposed. The peak firing rates were significantly different (P = 0.0004, unpaired t-
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test). The area under the curve of Aδ-fibres for the tails of rats that had been shielded 
was 50 ± 22 spikes and 180 ± 61 spikes for those rats the tails of which had been 
exposed. Their areas under the curve were significantly different (P < 0.0001, 
unpaired t-test). The area under the curve of C-fibres for the tails of rats which had 
been shielded was 56 ± 20 spikes and 166 ± 49 spikes for those rats the tails of which 
had been exposed. Their areas under the curve were significantly different (P = 
0.0001, unpaired t-test). 
 
Neural response to noxious blunt mechanical challenge 
 
The effect of UVA-light exposure on Aδ- and C-fibre responses to a noxious blunt 
challenge is shown in Figure 8 and Figure 9. We identified 7 Aδ-fibres and 6 C-fibres 
that were responsive to a blunt mechanical challenge in rats exposed to UVA-light, 
and 8 Aδ-fibres and 10 C-fibres that were responsive to a blunt mechanical challenge 
in rats shielded from UVA-light. Only one type of each fibre was identified in each 
animal. The peak firing rate of Aδ-fibres for the tails of rats which had been shielded 
was 31 ± 6 spikes.s-1 and 44 ± 14 spikes.s-1 for those rats the tails of which had been 
exposed. Their peak firing rates were significantly different (P = 0.02, unpaired t-test). 
The peak firing rate of C-fibres for the rats the tails of which had been shielded was 
25 ± 12 spikes.s-1 and 46 ± 25 spikes.s-1 for those rats the tails of which had been 
exposed. Their peak firing rates were significantly different (P = 0.04, unpaired t-test). 
The area under the curve of Aδ-fibres for the tails of rats which had been shielded was 
67 ± 22 spikes and 185 ± 47 spikes for those rats the tails of which had been exposed. 
Their areas under the curve were significantly different (P < 0.0001, unpaired t-test). 
The peak firing rate of C-fibres for the rats the tails of which had been shielded was 
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53 ± 18 spikes and 149 ± 40 spikes for those rats the tails of which had been exposed. 
Their areas under the curve were significantly different (P = 0.005, unpaired t-test). 
 
 
 
 82 
Discussion 
 
We investigated what effect UVA-light exposure of the rats’ tails would have on the 
sensitivity of nociceptive primary afferent fibres that innervate the rat tail. We did not 
investigate those afferents that responded to challenges both in the noxious and non-
noxious challenge ranges. After UVA-light exposure, we assessed Aδ- and C-fibre 
sensitivity by measuring area under the curve, a measure of firing rate over time, and 
peak firing rates. Both the area under the curve and the peak firing rates for the Aδ- 
and C-fibres were increased when the noxious blunt and punctate challenges were 
applied to the rat tail.  We have therefore shown that the Aδ- and C-fibres that 
encoded for noxious punctate and blunt challenges were sensitized after UVA-light 
exposure. The areas under the curve and the peak firing rate of C-fibres that were 
responsive to noxious thermal challenges were not increased after UVA-light 
exposure, that is, C-fibres responsible for encoding noxious thermal challenges were 
not sensitized by UVA-light exposure.  
 
The aim of this study was to determine whether changes within peripheral neurones 
could account for the modality specific hyperalgesia we previously observed after 
blocking the C-fibre barrage during UVA-light exposure, which prevented the 
development of thermal but not mechanical hyperalgesia 36. Although we investigated 
the firing properties of the fibres to a variety of noxious challenges, we did not 
describe the heat and mechanical thresholds, nor the full receptive field area of Aδ-
fibres nor C-fibres in this study. The reason for not describing these parameters was 
due to the instability of peripheral fibre preparations and deleterious effects of 
repeated noxious thermal and mechanical challenges on their receptive fields. 
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Dissection and recording from peripheral fibres was technically very difficult due to 
the fragility of fibres and their tendency to either stop firing or develop tachyphylaxis 
to the noxious challenges applied. We were therefore not able to measure all the 
possible parameters that would have been ideal, that was, their heat and mechanical 
thresholds, their full receptive field area and their responses to the variety of noxious 
challenges. We therefore prioritised our investigation to focus on those parameters 
that would be most helpful in either proving or disproving our hypothesis that primary 
mechanical hyperalgesia that was present 24 hours after UVA-light exposure was due 
to Aδ- and C-fibre sensitization, and that primary thermal hyperalgesia was not solely 
a peripherally mediated phenomenon.  
  
Our data seems to contradict studies that have shown that UV-light causes peripheral 
thermal sensitization 11,21,27,33. Polymodal receptors or silent nociceptors were 
sensitized after UV-light (spectrum not stated) exposure of rabbit ears 33, and UVB-
light exposure of rat hind paw 11, human skin 21 and pig skin 27. In this study, we used 
UVA-light, not UVB-light, to cause hyperalgesia, and UVA-light causes hyperalgesia 
though different mechanisms than does UVB-light. After UVA-light exposure of rat 
tail skin a mild chronic inflammatory response was evident histologically in rats 
exposed to UVA light as well as rats shielded from UVA-light, and the inflammatory 
process did not parallel hyperalgesia that was present 35. In addition, although the pro-
inflammatory mediators prostaglandins and histamine are increased after UVA-light 
exposure 15,17, only a handful of studies have reversed hyperalgesia through the 
administration of suitable anti-inflammatory agents, such as a cyclooxygenase 
inhibitor 24 and bradykinin antagonists 23,25. Therefore, there is minimal evidence to 
support the hypothesis that UVA-light causes an acute inflammatory hyperalgesia. In 
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contrast, the histological features after UVB-light exposure of human skin were 
consistent with an acute inflammatory response 15. In addition, there are numerous 
studies that show that UVB-light caused an increase in pro-inflammatory mediators 
such as prostaglandins 4,5, nitric oxide 26,34, pro-inflammatory cytokines 10,20,28, and 
nerve growth factor 16. Furthermore, UVB-light induced hyperalgesia can be reversed 
through the administration of suitable anti-inflammatory agents, such as 
cyclooxygenase inhibitors 2,3,32, and anti-inflammatory cytokines 28. Therefore, UVB-
light does cause an acute inflammatory hyperalgesia. It therefore follows that if UVA-
light causes hyperalgesia though different mechanisms than does UVB-light 
comparisons cannot be made between studies of different wavelengths. In the study 
described by Szolcsanyi 33 the spectrum of UV-light used was not described thereby 
precluding proper comparisons to other studies. In addition, no studies have described 
peripheral hypersensitivity to noxious thermal or mechanical challenges after UVA-
light exposure.  
 
The only study so far that has investigated peripheral neuronal hyperexcitability after 
UVA-light exposure of the rat hind paws showed an increase in spontaneous firing of 
polymodal receptors 1. We have not included the spontaneous firing rates of the fibres 
that we investigated. An increase in spontaneous firing indicates an increase in the 
sensitivity of the fibres measured, but does not discriminate as to which noxious 
challenges the fibres become sensitized. For, example an increase in the spontaneous 
firing rate of the C-fibre could represent an increase in sensitivity to noxious 
mechanical but not noxious thermal challenge. Any change in spontaneous firing does 
not alter our conclusions that Aδ- and C-fibres that encode for noxious punctate and 
 85 
blunt challenges were sensitized while C-fibres responsible for encoding noxious 
thermal challenges were not sensitized by UVA-light exposure. 
 
In our current study, we measured behavioural and neuronal responses 24 hours after 
UVA-light exposure. We have shown previously though that after such UVA-light 
exposure primary mechanical hyperalgesia to noxious challenges applied to the rat’s 
tail lasted for two weeks after the UVA-light exposure 35,36. Though sensitization of 
peripheral neurones could account for the hyperalgesia that was present to the blunt 
and punctate challenges one day after UVA-light exposure, we do not know whether 
that sensitization lasts long enough to account for the hyperalgesia observed two 
weeks after exposure to UVA light, whether there was prolonged input from rat tail 
nociceptors over the weeks, or whether a subsequent increase in dorsal horn 
sensitivity was responsible for the sustained mechanical hyperalgesia. Urban and 
colleagues 40 observed continuous low-threshold mechanoreceptor input to the dorsal 
horn over the first three days after brief UVA-light exposure of the rat hind-paw. 
Subsequently, the same group 37 showed enhanced summation of ventral root 
potentials, a measure of wind-up, in response to A- and C-fibre stimulation. In the 
animals in which we previously demonstrated prolonged hyperalgesia, continuous 
input from low-threshold mechanoreceptors after UVA-light exposure may have led to 
progressive wind-up in dorsal horn neurones and subsequent central sensitization 18. 
Determining the neuronal basis of the prolonged hyperalgesia would require a study 
in which primary afferent and dorsal horn neurones responses are measured in rats up 
to two weeks after UVA-light exposure.  
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It is not known what causes the peripheral sensitization of peripheral 
mechanoreceptive pathways after UVA-light exposure. It is not an inflammatory 
response at the exposure site, since we have shown histologically that at the site of 
exposure a mild chronic inflammatory cell infiltrate was present in rats whose tails 
were exposed to UVA-light and those that were shielded from UVA-light 35. However 
inflammatory mediators may be released without producing histological evidence of 
inflammation. Ischaemia and reperfusion of the rat tail causes a 60 minute 
hyperalgesia to noxious heat (49°C), reversible by anti-inflammatory drugs, without 
histological evidence of inflammation. Bradykinin and histamine are released during 
tail ischaemia and reperfusion, and contribute to the subsequent hyperalgesia 12,13.  
 
The concept that a conditioning event, UVA-light exposure in our case, can result in 
mechanical hyperalgesia, for which sensitization of primary afferent fibres may 
account, and thermal hyperalgesia, for which sensitization of primary afferent fibres 
does not account, is not a unique phenomenon. Intraplantar injection of bee venom in 
rats caused a centrally-mediated thermal hyperalgesia and a primary mechanical 
hyperalgesia 6,7,9. The thermal hyperalgesia was bilateral, but the mechanical 
hyperalgesia only ipsilateral 6,7. Contralateral hyperalgesia is a centrally-mediated 
phenomenon, which in the case of bee venom injection could be blocked by systemic 
administration of a non-competitive NMDA receptor antagonist 6,8.  
 
In conclusion, we have demonstrated that primary mechanical hyperalgesia 24 hours 
after UVA-light exposure is due to Aδ- and C-fibre sensitization. We have shown that 
the C-fibres responsible for encoding noxious thermal challenges were not sensitized 
24 hours after UVA-light exposure. We have therefore demonstrated that primary 
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thermal hyperalgesia was not solely a peripherally mediated phenomenon and may be 
caused by central sensitization. Such a paradigm shift may provide the answers to our 
poor success in treating chronic pain and the development of novel pharmacological 
targets and new treatment regimes.  
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Figure legends 
 
Figure 1: Mean (SD) tail flick latencies to a noxious theramal challenge (A), mean 
(SD) aversive pressure thresholds to a noxious punctuate mechanical challenge (B), 
and (C) mean (SD) aversive escape latencies to a noxious blunt mechanical challenge, 
before and one day after UVA-light exposure, for rats with tails that had been exposed 
(black bars, n = 19) and shielded (open bars, n = 16) during UVA light exposure. 
Exposure to UVA light resulted in significant decreases in tail flick latencies to the 
thermal challenge (A), pressure thresholds to the punctate mechanical challenge (B), 
and escape latencies to the blunt mechanical challenge (C).  There were no significant 
differences between the two groups (exposed and shielded) for any of the three 
measurements before exposure to UVA light, and no significant changes in tail flick 
latency, pressure thresholds or escape latencies occurred in the shielded animals 
before and after exposure to UVA light (* P < 0.05 exposed versus shielded, two-way 
ANOVA with Tukey post-hoc test ).  
 
Figure 2: Example of recording from two Aδ-fibres in rats whose tails had either 
been shielded (A) or exposed (B), to UVA light, and the respective fibre’s response to 
noxious punctate and blunt challenges. Arrows indicate when the challenge was 
applied. 
 
Figure 3: Example of recording from two C-fibres in rats whose tails had either been 
shielded (A) or exposed (B) to UVA light, and the respective fibre’s response to 
noxious thermal, punctate and blunt challenges. Arrows indicate when the challenge 
was applied. 
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Figure 4: Mean (SD) peak firing rates of thermally-sensitive C-fibres in response to 
49°C challenge in the receptive field, for rats with tails that had been shielded (open 
bars, n=11) and exposed (black bars, n=9) during UVA-light exposure. There were no 
differences in the peak firing rates between the two groups of rats.  
 
Figure 5: Mean (SD) area under the curve of thermally-sensitive C-fibres in response 
to 49°C challenge in the receptive field, for rats with tails that had been shielded 
(open bars, n=11) and exposed (black bars, n=9) during UVA-light exposure. There 
were no differences in the areas under the curve between the two groups of rats. 
 
Figure 6: Mean (SD) peak firing rates of mechanically-sensitive Aδ-fibres in 
response to a noxious punctate challenge for rats with tails that had been shielded 
(open bars, n=8) and exposed (black bars, n=7) during UVA-light exposure, and peak 
firing rates of mechanically-sensitive C-fibres in response to a noxious punctate 
challenge for rats with tails that had been shielded (open bars, n=8) and exposed 
(black bars, n=6) during UVA-light exposure. Peak firing rate for both the Aδ-and C-
fibres were increased significantly after UVA-light exposure (*P < 0.01, unpaired t-
tests). 
 
Figure 7: Mean (SD) area under the curve of mechanically-sensitive Aδ-fibres in 
response to a noxious punctate challenge for rats with tails that had been shielded 
(open bars, n=8) and exposed (black bars, n=7) during UVA-light exposure, and area 
under the curve of mechanically-sensitive C-fibres in response to a noxious punctate 
challenge for rats with tails that had been shielded (open bars, n=8) and exposed 
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(black bars, n=6) during UVA-light exposure. Area under the curve for both the Aδ- 
and C-fibres were increased significantly after UVA-light exposure (*P < 0.01, 
unpaired t-tests). 
 
Figure 8: Mean (SD) peak firing rates of mechanically-sensitive Aδ-fibres in 
response to a noxious blunt challenge in the receptive field, for rats with tails that had 
been shielded (open bars, n=8) and exposed (black bars, n=7) during UVA-light 
exposure, and peak firing rates of mechanically-sensitive C-fibres in response to a 
noxious blunt challenge for rats with tails that had been shielded (open bars, n=10) 
and exposed (black bars, n=6) during UVA-light exposure. Peak firing rate for both 
the Aδ- and C-fibres were increased significantly after UVA-light exposure (*P < 
0.01, unpaired t-tests). 
 
Figure 9: Mean (SD) area under the curve of mechanically-sensitive Aδ-fibres in 
response to a noxious blunt challenge in the receptive field, for rats with tails that had 
been shielded (open bars, n=8) and exposed (black bars, n=7) during UVA-light 
exposure, and area under the curve of mechanically-sensitive C-fibres in response to a 
noxious blunt challenge for rats with tails that had been exposed (shielded (open bars, 
n=10) and exposed (black bars, n=6) during UVA-light exposure. Area under the 
curve for both the Aδ- and C-fibres were increased significantly after UVA-light 
exposure (*P < 0.01, unpaired t-tests). 
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CHAPTER 5 
 
Conclusions 
 
 110 
Since it was first described in 1993, researchers have explored the physiological 
mechanisms through which UVA- and UVB-light cause sustained hyperalgesia.  UVB-
light causes acute inflammation with a subsequent inflammatory hyperalgesia, and its 
major advantage as an experimental tool for studying hyperalgesia is that relies on the 
release of endogenous compounds for the induction of hyperalgesia and it can be used 
both in humans and animals. Alternatively, UVA-light offers previously undescribed 
pathophysiological pathways to cause sustained hyperalgesia. In my thesis I 
completed three experiments, each concentrating on issues that have not been 
adequately addressed in the literature. In my first experiment I developed my own 
model of UVA-light induced hyperalgesia, independently verified the spectrum of my 
UVA-light and histologically determined whether inflammation was present after 
UVA-light exposure. In my second and third experiments I investigated the role of the 
C-fibre barrage and changes within peripheral afferent neurones after UVA-light 
exposure.  I have summarised the results of my experiments in this chapter. 
  
5.1 UV-light and behavioural hyperalgesia 
 
In order to investigate the pathophysiology of UVA-light I needed a protocol of UVA-
light exposure that would cause prolonged hyperalgesia to noxious thermal and 
mechanical challenges. After experimenting with multiple exposure durations and 
repetitions, I found that exposing the dorsal surface of rats’ tails to UVA-light eight 
times for 40 seconds each, with 260 seconds between each exposure, caused 
hyperalgesia to a noxious thermal challenge, a 49°C water bath, and two noxious 
mechanical challenges, a bar algometer that generated a suprathreshold noxious static 
force of 3.9 N (Chapter 2), and a noxious punctate challenge, an electronic von Frey 
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anaesthesiometer that generated progressively increasing pressures (Chapter 3). If I 
exposed rats’ tails to UVA-light for longer than 40 seconds the rats’ tails would 
become severely damaged and would be unsuitable for behavioural testing. If I used 
fewer than eight exposures the hyperalgesia would either not develop or would 
resolve too quickly. My exposure protocol did not resemble exposure protocols 
previously described, as a single 90-second exposure usually was sufficient to 
produce hyperalgesia, and I used the rat tail and not the rat hind paw, the usual 
substrate for pain testing (Perkins et al., 1992; Perkins et al., 1993; Perkins & Kelly, 
1993). I felt that the rats would suffer less having their tails be hyperalgesic as 
opposed to the load-bearing hind paw and my laboratory has far more experience in 
testing for pain using the rat tail than the rat hindpaw.  
 
Although my protocol was unusual it produced the desired results. After UVA-light 
exposure, the hyperalgesia to a noxious thermal challenge lasted for eight days, to a 
noxious blunt mechanical challenge for at least 16 days (Chapter 2), and to a noxious 
punctate challenge for at least 14 days (Chapter 3). I could not test mechanical 
hyperalgesia for longer because the rats outgrew their restrainers. The amplitude of 
the hyperalgesia was substantial, with the response latency to the noxious thermal 
challenge shortened by nearly a third in the hyperalgesic state, and the response 
latency to the noxious mechanical challenge shortened by over half.  
 
Despite the UVA-light causing a severe hyperalgesia, the rats were hyperalgesic for 
over two weeks, they did not exhibit signs of chronic distress, such as abnormal gait, 
reduced mobility, or reduced grooming when handled, and they gained body mass 
over the duration of the various experiments at the same rate as those rats shielded 
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from the UVA-light (Chapter 2). There are animal models that cause hyperalgesia that 
lasts for weeks to months (Chapter 2, Table 1) that aim to mimic clinical conditions 
such as rheumatoid arthritis, osteo-arthritis, peripheral neuropathy and fibromyalgia. 
However, the conditioning events necessary to induce long-lasting hyperalgesia leave 
the experimental animals in persistent pain that not only confounds responses to 
evoked pain, but also compromises the health of the animals, which characteristically 
lose mass, show an abnormal gait, reduced mobility, reduced grooming and disturbed 
sleep (Blackburn-Munro, 2004). My model displays the longest-lasting experimental 
hyperalgesia reported so far during which the experimental animals gain weight and 
appear to be healthy and pain-free. Not only were they free of impaired mobility 
associated with long-lasting hyperalgesia, but, because the hyperalgesia was produced 
in the tail, not the hind paw, they also were free of the impaired mobility associated 
with any lesions of the foot.  
 
Although the rat tail offers many advantages, a significant disadvantage of using the  
tail as opposed to the hindpaw was that I was unable to assess for central neuronal 
changes by measuring behavioural changes within the contralateral appendage. 
However, measuring mechanical allodynia may offer an alternative assessment of 
central neuronal changes and is worthy of further investigation.  
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5.2 UV-light lamp 
 
I used a double-ended high-pressure metal halide UVA lamp as the source of UVA-
light in all my studies. For the purposes of my first study (Chapter 2), I commissioned 
experts at the Council for Scientific and Industrial Research, Tshwane, South Africa, 
to measure the spectrum of UV-light emitted by my lamp. They independently 
verified that my lamp emitted light predominantly in the UVA-light spectrum.  It had a 
spectral irradiance of 37 mW.cm-2, with 60 % of the energy emitted in the UVA range, 
30% in the UVB range and 10% in the UVC range, in the steady state (Figure 1).  
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Figure 1: Spectral irradiance of UV-light lamp 
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Although the lamp emitted light predominantly in the UVA-light spectrum, it began to 
emit a significant portion of light in the UVB-light spectrum 30 seconds after the lamp 
was activated (Chapter 2). In my studies the lamp was activated only for 40-second 
pulses, and since my lamp began to emit UVB-light only 30 seconds after the lamp 
was switched on, UVB-light was unlikely to have contaminated my studies. I am 
therefore confident that my findings were as a result of the biological effects of UVA-
light, and not UVB-light.  
 
However, in none of the reports from the laboratories that have studied UV-light 
induced hyperalgesia states that the nature of the lamp used to generate UV-light had 
been independently verified. In previous studies where UVA-light was the 
conditioning challenge, the lamps were activated for 90 seconds (Perkins et al., 1992; 
Perkins et al., 1993; Perkins & Kelly, 1993), and if their lamps were similar to the one 
I used in my studies, the rat tissues would have been exposed to UVB-light for at least 
60 seconds. Since the lamps were not independently verified, it was entirely possible 
that UVB-light contaminated those studies. Contamination by UVB-light has 
significant implications, as UVB-light can produce inflammation and hyperalgesia at 
substantially lower energy levels and through different mechanisms than does UVA-
light, as explained in my Introduction. Therefore, in studies where UVA-light was the 
proposed conditioning event, it was possible that UVB-light was causing the 
hyperalgesia and their findings are as a result of inflammation caused by UVB-light.  
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5.3 UV-light induced inflammation 
 
A long-held and plausible assumption has been that UV-light, including UVA- and 
UVB-light, caused an inflammatory hyperalgesia (Davies et al., 2005). Exposure of 
skin, rodent and human, to UV-light causes erythema, increased tissue temperature, 
oedema, pain and pruritus, characteristic clinical features of inflammation. 
Histological sections of human tissue after UVB-light irradiation revealed a typical 
acute inflammatory cascade within the epidermis and dermis, an initial vasodilatation 
of blood vessels followed by a inflammatory cell infiltrate consisting primarily of 
neutrophils, T lymphocytes and mononuclear cells (Gilchrest et al., 1981). Therefore, 
the histological features of acute inflammation after UVB-light exposure are consistent 
with the clinical picture of the inflammatory process that follows UV-light exposure. 
However, the histological changes that occur after UVA-light exposure do not parallel 
the features of acute inflammation. Histological sections of UVA-light irradiated 
human tissues typically reveal significant dermal injury with a mixed perivascular 
cellular infiltrate, consisting of predominantly monocytes and T lymphocytes with 
few neutrophils, encroached on the deeper dermal vessels (Kumakiri et al., 1977; 
Gilchrest et al., 1983). There is no epidermal injury and a complete absence of 
inflammatory cells within the epidermis (Soter, 1990). Therefore, UVA-light causes a 
pattern of injury completely different to that of UVB-light.  
 
It therefore was of vital importance to examine the rat tail tissue histologically after 
UVA-light exposure to confirm the presence, or absence, of inflammation after UVA-
light irradiation, and to determine whether the tissue response to UVA-light correlated 
with the hyperalgesia that was present. Since animal tissue never has been examined 
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histologically after UV-light, neither UVA- nor UVB-light, exposure as far as I could 
establish, there were a number of possibilities to consider. It may be that animal tissue 
responds differently to UVA-light than human tissue and UVA-light may cause an 
acute inflammatory response in rats that corresponds with the hyperalgesia, as UVB-
light does in human tissue. Or UVA-light may cause a similar response in rat tissue as 
in human tissue and an acute inflammatory response may not be responsible for UVA-
light induced hyperalgesia. In my first study (Chapter 2) I sought to answer the above 
questions. 
 
In my first study, I examined rat tail tissue histologically at the site of UVA-light 
irradiation for inflammation (Themistocleous et al., 2006). There was no evidence of 
acute inflammation, but I discovered mild chronic inflammation at the target site of 
irradiation both in those rats irradiated with UVA-light and in those rats shielded form 
the UVA-light. There were scattered lymphocytes and plasma cells within the dermis, 
and there was no change in the severity of inflammation one to nine after days after 
UVA-light exposure. The rats shielded from the UVA-light never were hyperalgesic, 
so the sustained hyperalgesia in irradiated rats I observed was unlikely to have been 
caused or maintained by the mild inflammation. The cause of the mild chronic 
inflammation was not clear, but I think it was caused by tail hyperthermia, which in 
turn was caused by an increase in temperature within the UVA-light rig. The air in the 
UVA light rig reached a peak temperature of about 45°C during activation of the UVA-
light lamp, probably because the UVA-light rig was poorly ventilated. Even if 
hyperthermia was the cause of the mild chronic inflammation it did not cause 
hyperalgesia, as the rats shielded from the UVA-light did not develop hyperalgesia, 
and so did not confound my main results. Whatever the events were which led to the 
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hyperalgesia, they were not visible under light microscopy in the irradiated tissue. It is 
not to say that components of the inflammatory soup may not still be involved, as in 
reperfusion hyperalgesia, where anti-inflammatory agents are anti-hyperalgesic in the 
absence of clinical and histological features of inflammation (Gelgor et al., 1986a; 
Gelgor et al., 1992a; Gelgor et al., 1992b; Vidulich & Mitchell, 2000). 
 
There is evidence that some components of the inflammatory soup are involved in at 
least initiating UVA-light induced hyperalgesia. Prostaglandins and histamine are 
increased after UVA-light exposure of skin (Gilchrest et al., 1981; Hawk et al., 1983). 
Furthermore, bradykinin receptor antagonists and prostaglandin synthesis inhibitors, 
such as ibuprofen, a non-selective COX inhibitor, can attenuate UVA-light 
hyperalgesia when administered at the onset of hyperalgesia (Perkins et al., 1992; 
Perkins et al., 1993; Perkins & Kelly, 1993). A proviso to the studies that 
demonstrated an increase in pro-inflammatory mediators or the efficacy of anti-
inflammatory agents in relieving hyperalgesia is that since the UV-light lamps were 
not independently verified and their UV-light spectrum characterised it is possible 
that UVB-light contaminated their studies. If this occurred the increase in 
inflammatory mediators, and subsequent efficacy of anti-inflammatory agents, may 
reflect the effects of UVB-light and not UVA-light. Ultimately more studies have to be 
done to determine the exact role of pro-inflammatory mediators in UVA-light induced 
hyperalgesia. Pro-inflammatory antagonists would have to be administered, and pro-
inflammatory mediators measured, at different points in the time course of the 
hyperalgesia, such as at the onset of UVA-light induced hyperalgesia, and at intervals 
after the onset of UVA-light induced hyperalgesia. In addition, the various pro-
inflammatory antagonists would be administered at various locations within the 
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neuraxis, such as the spinal cord or cerebral ventricles, to determine their point of 
action. 
 
Irrespective of the role of pro-inflammatory mediators, UVA-light induced 
hyperalgesia provides an alternative to almost all current animal models of 
hyperalgesia that rely on initiating inflammation to cause hyperalgesia. In almost all 
models of hyperalgesia, inflammation parallels the duration and severity of 
hyperalgesia (Vinegar et al., 1987; Diehl et al., 1988; Weber et al., 2005). For 
example, carrageenan injected into the paw of rats and cats (Vinegar et al., 1987; 
Diehl et al., 1988) or incision of the rat tail (Weber et al., 2005) causes hyperalgesia 
to either a noxious thermal or mechanical challenge that parallels the onset and 
resolution of the acute inflammatory response. The major advantage is that 
experimental hyperalgesia without inflammation provides a template for the testing of 
putative antihyperalgesic agents, because agents that relieve such hyperalgesia must 
act through antinociceptive rather than anti-inflammatory mechanisms.  
 
5.4 UV-light and altered neuronal firing 
 
My investigations of UVA-light induced hyperalgesia began by exploring the first step 
in central sensitization, the C fibre barrage. The C-fibre barrage, activation of C-fibre 
neurones during a conditioning challenge, alter WDR neurones such that the WDR 
are sensitized for a duration that exceed both the conditioning challenge and the C-
fibre barrage (Dickenson & Sullivan, 1987; Woolf, 1989; Thompson et al., 1993b; 
Vatine et al., 1998; Ji et al., 2003). Consequently, blocking the C-fibre barrage with 
local anaesthetics decreases the severity and duration of hyperalgesia in certain 
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animal models of chronic pain (Gonzalez-Darder et al., 1986; Seltzer et al., 1991; 
Duarte et al., 2005), as well as post-incisional allodynia in humans (Gordon et al., 
1997). Since UVA-light irradiation of the rat hindpaw caused sensitization of WDR 
neurones (Urban et al., 1993), I injected bupivacaine, a long-lasting local anaesthetic, 
into the base of rats’ tails before UVA-light irradiation in order to block the C-fibre 
barrage (Chapter 3).  
 
Bupivacaine injection into the base of the rat tail before UVA-light exposure 
prevented the development of hyperalgesia to a subsequent noxious thermal 
challenge, but did not affect the development of primary hyperalgesia to a noxious 
punctate mechanical challenge (Themistocleous et al., 2007). Adequate afferent 
neuronal activity during UVA-light exposure was therefore critical for the 
development of thermal, but not mechanical hyperalgesia, and my study suggested 
that thermal hyperalgesia after UVA-light exposure was caused solely by central 
sensitization. If sensitization of peripheral thermal nociceptors occurred then thermal 
hyperalgesia would have developed once the bupivacaine had worn off, on the second 
or later days. Centrally mediated thermal hyperalgesia is not without precedent. 
Subcutaneous bee venom injection also caused a centrally mediated thermal 
hyperalgesia (Chen et al., 1999; Chen & Chen, 2000; Chen et al., 2000). Intraplantar 
injection of bee venom caused a contralateral thermal hyperalgesia, and the 
contralateral thermal hyperalgesia was a centrally mediated phenomenon that was 
blocked through the systemic administration of a NMDA receptor antagonist (Chen & 
Chen, 2000; Chen et al., 2003). Despite preventing the development of thermal 
hyperalgesia, interfering with the C-fibre barrage did not prevent the development of 
primary hyperalgesia to a noxious punctate mechanical challenge.  
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It may be that the mechanical hyperalgesia depended on sensitization processes 
activated by myelinated afferent pathways (Meyer & Treede, 2004), which were not 
disabled by the local anaesthesia. Prolonged peripheral neuronal sensitization was 
probably responsible for the mechanical hyperalgesia; however, it still was possible 
that central sensitization occurred independent of an initial C-fibre. Indeed, Urban and 
colleagues (1993) observed continuous low-threshold mechanoreceptor input to the 
dorsal horn over the first three days after UVA-light exposure of the rat hind-paw. 
Subsequently, the same group (Thompson et al., 1994) showed enhanced summation 
of ventral root potentials, a measure of wind-up, in response to C- and A-fibre 
stimulation. Therefore in our animals, continuous input from low-threshold 
mechanoreceptor after UVA-light exposure may have led to progressive wind-up in 
dorsal horn neurones (Herrero et al., 2000) with subsequent central sensitization 
independent of an initial C-fibre barrage during UVA-light exposure. To resolve the 
mechanisms contributing to the development and maintenance of the mechanical 
hyperalgesia I measured responses from the primary afferent neurones of the rat tail 
after UVA-light exposure (Chapter 4).  
 
In my third study (Chapter 4), I investigated the effect UVA-light exposure of the rat 
tail on primary afferent fibres that innervate the rat tail, to determine whether changes 
within peripheral neurones could have accounted for the modality specific 
hyperalgesia observed after I blocked the C-fibre barrage and prevented the 
development of thermal but not mechanical hyperalgesia. I focused on nociceptive 
afferents and did not investigate those afferents that would respond to challenges both 
in the noxious and non-noxious ranges. The major finding of my third study was that I 
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discovered a population of peripheral afferent fibres with electrophysiological 
properties consistent with the behavioural hyperalgesia that developed after UVA-light 
exposure. The peak firing rates and areas under the curve of post-challenge time 
histograms, a measure of firing rate over time, of both the Aδ- and C-fibres were 
increased when noxious blunt and punctate challenges were applied to the rat tail.  I 
therefore had shown that the Aδ- and C-fibres that encode for noxious punctate and 
blunt mechanical challenges were sensitized after UVA-light exposure. However, the 
peak firing rate and areas under the curve of post-challenge time histograms, a 
measure of firing rate over time, of C-fibres that were responsive to noxious thermal 
challenges were not increased after UVA-light exposure. Therefore, C-fibres 
responsible for encoding noxious thermal challenges were not sensitized by UVA-light 
exposure. I therefore had discovered alterations in peripheral afferent fibres that could 
account for the modality-specific hyperalgesia. However, since I did not investigate 
the firing properties of all peripheral afferent neurones, for example neurones that 
would respond to challenges both in the noxious and non-noxious ranges, there may 
be other mechanisms that contribute to UVA-light hyperalgesia. 
 
Hyperalgesia to blunt and punctate mechanical challenges after UVA-light exposure of 
the rat tail lasted for at least two weeks. I measured neuronal responses one day after 
UVA-light exposure. Therefore, sensitization of peripheral neurones could account for 
the hyperalgesia that was present to the blunt and punctate challenges one day after 
UVA-light exposure, but I do not know whether the peripheral sensitization lasted 
long enough to account for the prolonged behavioural hyperalgesia. It may be that 
increased input from sensitized peripheral afferent neurones altered WDR neurones 
independently of a C-fibre barrage and thus was responsible for the sustained 
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mechanical hyperalgesia, or sensitized WDR neurones and peripheral afferent 
neurones together account for the prolonged behavioural hyperalgesia. If peripheral 
sensitization does account for prolonged behavioural hyperalgesia it may be that 
UVA-light acting through chromophores permanently altered peripheral afferent 
neurones. These changes may have caused the change in the sensitivity of peripheral 
nociceptors specific for mechanotransduction in our rats in the absence of overt 
histological signs of inflammation, and thereby account for undetected peripheral 
mechanisms for the sustained hyperalgesia we observed. Ultimately, determining the 
neuronal basis of the prolonged hyperalgesia would require a study in which primary 
afferent and dorsal horn neurones responses are measured in rats up to two weeks 
after UVA-light exposure. 
 
In contrast to their sensitization to noxious mechanical challenges, peripheral afferent 
neurones were not sensitized to noxious thermal challenge. Such a finding was in 
keeping with the data from my second study whereby abolishing the C-fibre barrage 
and subsequent central sensitization prevented the development of sustained thermal 
hyperalgesia. Therefore, it is possible that thermal hyperalgesia after UVA-light 
exposure of the rat tail was caused by central sensitization. It is possible that after 
UVA-light exposure of the rat tail a sub-population of neurones within the spinal cord 
became sensitized to noxious thermal challenges, as was seen after intraplantar 
injection of bee venom, which was a central NMDA receptor mediated phenomenon 
(Chen & Chen, 2000; Chen et al., 2003). Determining the neuronal basis of the 
thermal hyperalgesia would require a study in which WDR dorsal horn neurones 
responses are measured after UVA-light exposure, as well as determining whether 
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WDR dorsal horn neurones responses are altered with the addition of suitable 
antagonists, such as NMDA receptor antagonists. 
 
In my thesis I have developed my own model of UVA-light hyperalgesia, which 
causes sustained behavioural hyperalgesia to noxious mechanical and thermal 
challenges. I independently verified that my UV-light lamp emitted light 
predominantly in the UVA spectrum, and confirmed histologically that UVA-light 
does not cause inflammation. The sustained mechanical hyperalgesia did not depend 
on the activation of the C-fibre barrage, but thermal hyperalgesia did depend on the 
activation of a C-fibre barrage during the conditioning event of UVA-light exposure. 
Furthermore, I demonstrated that primary mechanical hyperalgesia was in part due to 
Aδ and C-fibre sensitization, and C-fibres responsible for encoding noxious thermal 
challenges were not sensitized after UVA-light exposure. I have therefore 
demonstrated that primary thermal hyperalgesia is not solely a peripherally mediated 
phenomenon. I believe that the pathophysiological mechanisms that cause 
hyperalgesia differ according to the conditioning event. Thermal hyperalgesia after 
peripheral inflammation and nerve injury is caused by primary afferent sensitization 
and mechanical hyperalgesia is caused by central sensitization. After bee venom 
injection and UVA-light exposure the reverse is true, that is, thermal hyperalgesia is 
caused by central sensitisation and mechanical hyperalgesia is caused by primary 
afferent sensitisation. Such a paradigm shift may provide the answers to our poor 
success in treating chronic pain and the development of novel pharmacological targets 
and new treatment regimes. 
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